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2. Abstract
Lymph nodes belong to the main actors in adaptive immunity, as they accommodate
the cells  of  our  acquired immunology,  namely dendritic  cells,  T-cells  and B-cells.
Moreover they are its infrastructural and functional junction as immune cells, antigen
and  cytokines  permanently  flow  through  these  secondary  lymphatic  organs.
Therefore they are in need of cells which support  as well  as maintain the lymph
node's structure and possess the ability to provide a proper immune response. This
task is mainly fulfilled by so called fibroblastic reticular cells, which belong, next to
lymphatic endothelial cells and blood endothelial cells, to mesenchymal stromal cells
and are the main focus of research. This work focuses on how stromal cells in lymph
nodes are influenced by diet. Since famine is not just an important issue in third world
countries,  but  also in western countries, special  diets and malnutrition caused by
cancer are an every day epiphany.  Hence it  is  an interesting question how diets
impact the lymph node's cellular structure.
We have established an experimental system to study the effect of acute starvation in
secondary  lymphoid  organs  and  to  follow  the  alterations  associated  with  the
regression phase when food is again accessible. During short-term starvation and
regression phase stromal cell populations decreased in lymph nodes. This change
reflected the decrease of cell populations in absolute numbers, while the proportions
in  the  frequency of  stromal  subpopulations  remained  the  same.  Additionally,  the
regression phase was associated with decreased podoplanin expression in stromal
cells,  in  particular  in  FRCs.  To  identify  possible  mechanism for  the  decrease  in
stromal  cell  populations,  we  addressed  leptin-leptin  receptor  pathway  in  SLOs.
Indeed, we have identified leptin receptor variants in fibroblastic reticular cells (FRCs)
where Western blot analysis revealed that next to an unfunctional knock-out receptor
there is also the long functional LepRb isoform expressed. Addition of leptin during
starvation is suspected to partially protect cell loss in lymph nodes. Yet more details
about  fibroblastic  reticular  cells'  physiology have to  be revealed in  future  studies
regarding leptin signaling in lymph nodes as well as the return to status quo after the
beginning of the regression phase.
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Da  Lymphknoten  die  angepasstesten  Zellen  des  erworbenen  Immunsystems
beherbergen, nämlich dendritische Zellen, T-Zellen und B-Zellen, gehören sie zu den
wichtigsten Schauplätzen der  erworbenen Immunität.  Sie  sind als  infrastrukturelle
und  funktionelle  Knotenpunkte  im  immunologischen  Geschehen  zu  bewerten:
Antigene  und  Cytokine  kommen  ständig  in  Kontakt  mit  diesen  sekundären
lymphatischen  Organen,  daher  werden  spezialisierte  Zellen  benötigt,  welche  die
Struktur des Lymphknotens erhalten, sowie die Befähigung besitzen, eine adäquate
Immunantwort  zu  unterstützen.  Diese  Aufgabe  wird  vor  Allem  durch  sogenannte
fibroblastische  retikuläre  Zellen  übernommen.  Diese  Zellen  gehören  neben
lymphatischen  Endothelzellen  und  Blutendothelzellen  zu  den  sogenannten
mesenchymalen Stromazellen.  Auf  sie  wird in  dieser  Arbeit  das Hauptaugenmerk
gelegt, wobei der Fokus auf dem Einfluss bestimmter Ernährungszustände auf die im
Lymphknoten  ansässigen  Stromazellen  liegt.  Entgegen  der  populären  Meinung,
Mangel- und Unterernährung sei nur eine Problematik die Drittweltländer betrifft, lässt
sich kundtun, dass beide Formen durch spezielle Diäten oder malignomassoziierte
Malnutrition  auch  als  ein  Phänomen  westlicher  Kulturkreise  häufig  angetroffen
werden können. Daher ist die Klärung der Frage, inwiefern diese Ernährungsformen
die  Struktur  von  Lymphknoten  auf  zellulärer  Ebene  verändern  von  höchster
Wichtigkeit.
Wir haben einen experimentellen Aufbau entwickelt mit dem wir die Auswirkungen,
die  eine  akute  Hungerphase  sowie  die  darauffolgende  Erholungsphase  bei
Renutrition  auf  den  Lymphknoten  hat,  erforschen  konnten.  Während  einer
kurzfristigen  Hungerphase  und  der  darauffolgenden  Erholung  konnte  beobachtet
werden, dass die Populationen der verschiedenen Stromazellen untergehen. Dies
zeigte sich in dem Abfall der absoluten Zellzahlen im Lymphknoten, wohingegen die
Zusammensetzung der gesamten Stromazellpopulation unaffektiert blieb. Außerdem
kam  es  in  der  Erholungsphase  zu  einer  verminderten  Podoplaninexpression  der
Stromazellen,  insbesondere  in  FRC.  Um  einen  möglichen  Mechanismus  für  den
Untergang von  Stromazellpopulationen  aufzudecken,  untersuchten wir  die  Leptin-
Leptinrezeptor Signalkaskade in SLO. Tatsächlich konnten wir veschiedene Varianten
des  Leptinrezeptors  auf  FRC  feststellen:  Western  Blot  Analysen  ergaben,  dass
5
neben einem knock-out-Rezeptor auch die lange, funktionstüchtige Isoform LepRb
exprimiert wird. Die Zugabe von Leptin während der Hungerphase wird verdächtigt
die  Zellen  im  Lymphknoten  teilweise  vor  zellulärem  Untergang  zu  schützen.  Es
müssen  jedoch  noch  weitere  unklare  Sachstände  zu  der  Physiologie  von  FRC
erörtert werden. Dazu gehört insbesondere die Signalkaskade des Leptinrezeptors
und wann die Struktur des Lymphknotenstromas nach Beginn der Erholungsphase
zum Status quo zurückkehrt.
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3. Introduction
3.1 Characterization of the lymphatic system in general
To provide  and ensure a  proper  function  of  the acquired  immune system,  lymph
nodes are placed strategically in the whole body.  Especially there where vessels
build crossroads, one can find lymph nodes which in mammals finally drain towards
the thoracic duct that discharges into the venous blood system. Lymph nodes are so
called secondary lymphatic organs, often just called SLOs. In contrast to the primary
lymphoid organs such as the  thymus and the bone marrow,  lymphocytes  do not
origin in SLOs, they migrate from their related primary lymphatic organ to the lymph
node, MALT (mucosa associated lymphatic tissue, to which belong tonsills, Peyer's
plaques, the Appendix vermiformis and all lymph follicles in mucosa) or spleen. Only
non MALT lymph nodes are subject of this thesis. The lymph fluid, which passes all
the lymphoid structures but the spleen, is a super filtrate of arterial blood that is first
collected by lymph capillaries which begin cul-du-sac or as plexus and then drain
towards  the  lymph  nodes.  As  they  reach  the  lymph  node,  they  empty  into  the
subcapsular zone that verges on the paracortical B-cell-zone which surrounds the
cortical T-cell-zone. The T-cell-zone again encloses the medulla which faces towards
the hilus and contains a high number of macrophages [196,  84, 117]. Lymph nodes
all  posses  a  characteristic  structure,  the  scaffold  of  the  lymph  node  is  build  by
fibroblastic  reticular  cells  that  form  an  aqueduct-like  system  with  their  cell  body
extensions, which is crucial for the role of chemokine, dendritic cell, B- and T-cell
transport  through  the  lymph  node.  Since  every  T-cell  only  recognizes  a  specific
antigen, it is crucial for the mounting of a immune response to ensure that they meet
their related antigen presented by the dendritic cell  in the lymph node, while they
circulate between the secondary lymphoid organs [93, 107, 13, 14, 176, 26]. Marginal
reticular cells in the subcapsular sinus and follicular dendritic cells (characterized by
their  surface  markers  gp38+,  CD31-,ER-TR17-,  CD35+  [32])  support  B-cells  via
chemokines and provide survival factors for them such as APRIL and BAFF [32]. The
structure of the B-cell-zone is different in primary and secondary follicles [107, 93,
100,  13, 153, 49, 71, 96]. Primary follicles only exist in lymph nodes which hadn't
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encountered antigen yet and are characterized by a homogeneous dispersal of small
lymphocytes. When first encountering an antigen by co-stimulation of T-helper-cells,
germinal centers develop within the follicle. Secondary follicles posses a cortex of
densely gathered emigrating and non-activated lymphocytes, which is asymmetrically
formed around the follicle being smaller towards the T-cell-zone side. The germinal
center is not as cell dense as the cortex, for it is build up by follicular dendritic cells,
macrophages,  B-cells,  few  T-helper-cells  providing  survival  signals  for  positively
selected B-cells and can again be subdivided under morphological aspects: a darker
and a lighter region. In the darker region mitotic expansion of centroblasts, which
have  been  stimulated  by  T-helper-cells,  occurs  after  they  moved  there  from the
lighter region. The so-called somatic hypermutation of the genes encoding the V-
region of the antigen receptor happens in this phase, resulting in stronger or weaker
affinity  for  the  corresponding  antigen.  Next  to  centroblasts,  also  centrocytes
reexpressing the mutated surface markers appear and migrate to the basal lighter
zone where they are being selected by antigen-presenting follicular dendritic cells
and  lots  of  centroblasts  undergo  apoptosis.  The  apoptotic  bodies  are  then
phagocyted by tingible-body macrophages. If positively selected they move towards
the apical light zone in which they differentiate towards plasma cells or B-memory-
cells and afterwards migrate out of the germinal center [59, 107]. Next to the B-cell-
zone the T-cell-zone is located, which contains many high endothelial venules. The
high endothelial venule allows cells via diapedesis to enter the lymph node from the
blood  system.  Homing  receptors  on  the  T-cells  and  adressines  on  the  endothel
enable the possibility for hematopoetic cells to return to the lymph node [107]. The T-
cell-zone is inhabited mostly by T-cells and dendritic cells. Upon inflammation, the
lymph node increases in size as lymphocytes stream into the lymph node. Not just
the number of cells changes in inflamed lymph node, but also its structure, known as
lymph  node  remodeling:  high  endothelial  venules  proliferate  as  they  reconstruct
them, B-cell-follicles are enlarged, and the lymph node scaffold changes as stromal
cells  proliferate  strongly  and  remodel  the  structure  via  their  extracellular  matrix
production. When being infected by Lymphocytic Choriomeningitis Virus, FRCs are
being attacked by cytotoxic T-lymphocytes as the FRCs are infected by the virus. The
outcome of this is due to reduced FRC numbers: Their  network is disrupted and
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recruitment, survival and migration of lymphocytes is deranged, resulting in reduced
immune  defense  [93, 206].  B-Cells  develop  in  the  bone  marrow  and  each
developmental stage of these cells can be identified by their surface markers. After
they matured and became immune competent, they leave the bone marrow for the
periphery. T-cells present in the thymus. The major part of T-cells though (ca. 95% to
98%) [107, 149], is being killed by apoptosis due to central tolerance. By somatic
rearrangement of the genes which code for the recognition domain, both B- and T-
cells gain a formidable variety of receptor variants which recognize a vast spectrum
of  antigen  specificity.  All  lymphocytes  carrying  genetically  and  phenotypically  the
same receptor are called clones and they descend from one progenitor cell [107]. An
important actor of the acquired immune system is the so called dendritic cell (DC).
The first presentation of antigen after subcutaneous injection is mediated by lymph
node resident DCs, a second antigen presentation happens 8 to 12h after injection
by DCs which migrated from the periphery after antigen contact [172, 80, 81]. Sixt et
al. have shown that around 60% of the resident CD11c positive DCs in the lymph
node and 80% of the myeloid resident lymph node CD11b positive DCs of the T-cell
area are directly connected to the fibers of the reticular network [172]. Surprisingly,
mature dendritic cells that migrated to the lymph node are only in 19% associated
with the reticular fiber network [172]. In order to recognize an antigen, B- and T-cells
carry a different type of antigen receptor on their surface, B-cells posses an immune
globulin as antigen receptor which is able to bind the antigen as a whole, whereas
the T-cell-receptor is only capable of binding peptide fragments,  whose precursor
protein has already been processed in a cell and presented by MHC class II or MHC
class I [107]. 
“The T-cell  receptor (TCR) consists of  a disulfide-linked heterodimer of the highly
variable α and β chains expressed at  the cell  membrane as a complex with  the
invariant CD3 chains. T-cells carrying this type of receptor are often called α:β T cells.
An alternative receptor made up of variable γ and δ chains is expressed with CD3 on
a subset of T cells. Both of these receptors are expressed with a disulfide-linked
homodimer of ζ chains.“ (Exact quote from Janeway et al.)[82] 
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T-cells can be subdivided generally in two classes: CD4+ T-helper-cells (which can
further be distinguished into at least these four important subtypes: T1-helper-cells,
T2-helper-cells, T17-helper-cells and regulatory T-cells) and CD8+ cytotoxic T-cells.
Although being closely related, these cells vary in the composition of their surface
markers  and  other  translated  proteins  and  consequently  in  their  role  in
immunobiology from each other  [107].  The defining surface molecules of the two
classes are a co-receptor of  the T-cell-receptor,  only binding specifically to  either
MHC-class-I or MHC-class-II, namely CD4 binding specifically to MHC-class-II and
CD8 binding specifically to MHC-class-I.  While MHC-class-I is present on all  cells
with a nucleus, presenting processed protein, MHC-class-II is only present on B-cells,
dendritic  cells  and  macrophages.  MHC-class-II  is  loaded  in  the  endosome  after
phagocytosis  of  an  antigen  [149].  This  explains  the  different  roles  of  the  T-
lymphocytes  and  immunoactive  cells.  Whereas  MHC-class-I  triggers  an  immune
response when presenting an antigen of its virus infected host cell or protein of an
altered host cell and thus signaling for a cytotoxic T-cell [149]. Embryonic lymph node
development is largely carried by lymphoid tissue inducer cells (LTi-cells) and stromal
cells. Stromal cells are believed to be the first local cells in lymph node development,
upon stimulation by retinoic acid they produce and release CXCL13 that recruit not
just lymphoid tissue inducer cells but also their precursors [93, 58, 174]. When the
present  stromal  cells'  lymphotoxin  beta  receptors are stimulated by the  lymphoid
tissue  inducer  cells'  lymphotoxin  (LT)αβ, they  differentiate  into  lymphoid  tissue
organizer  cells  which  in  addition to  CXCL13 produce CCL21,  CCL19,  (VCAM)-1,
(MadCAM)-1, VEGF-C, IL-17 and TRANCE that promote vascularization [203, 192,
93, 88].  Furthermore,  more  lymphoid  tissue  inducer  cells  and  precursors  are
recruited  to  the  place  of  action,  providing  further  survival  signals  for  them.  The
attracted  lymphoid  tissue  inducer  cells  and  the  pre-lymphoid  tissue  inducer  cells
create a positive enhancement concerning the stimulation by mesenchymal stromal
cells [192, 93].
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3.1.1 Characterization of fibroblastic reticular cells
Fibroblastic reticular cells (FRCs) are stromal cells which belong to mesenchymal
stromal cells to which also marginal reticular cells (MRC) of the subcapsular sinus of
the lymph node are counted [32]. FRCs inhabit secondary lymphoid organs [5] and
their morphology covers fusiform, elongated and stellate phenotypes, which however
is  dependent  on  their  location  inside  the  lymph  node  [5,  40,48].  Cortical  FRCs,
situated  next  to  the  subcapsular  sinus,  posses  a  polarized  or  fusiform  structure
(some of those FRCs are orientated parallel to the sinus, others are oriented vertical
to the sinus, having more of a polarized structure and reaching from the sinus far into
the  cortex)  [5,  48].  T-cell-zone  Fibroblastic  Reticular  Cells  (TRCs)  and  Follicular
Dendritic Cells (FDCs) are of a three dimensional stellate morphology  [15, 13, 48,
38]. Fibroblastic reticular cells produce extracellular matrix, consisting of molecules
such as ER-TR7 and collagens, which generates a three dimensional scaffold that
ranges from the subcapsular and paracortical sinus to the blood vessels [28, 87, 191,
189, 71, 91, 7, 135]. This scaffold provides space for the migration of lymphocytes,
dendritic cells, and also the conduit system that channels soluble molecules from the
afferent lymph towards the high endothelial venules (see figure 2)[152, 26, 114, 172].
This  cysternic  system is  called  reticular  fiber  network  by some authors  [5],  as  it
consists of cellular tails and both, fibrillar and collagen strands [48, 120, 134]. The
reticular fiber network is structured as follows: The reticular fiber network consists of
a collagen type 1 strand, being enveloped by basement membrane molecules, such
as collagen type 4, laminins, perlecan, proteoglycan, and nidogen, which are again
covered  by smooth  muscle  actin  and desmin  [172].  Different  than  expected,  the
reticular  fiber  network  is  not  entirely  wrapped by fibroblastic  reticular  cells,  even
though this is the main cell  type that covers it.  Around 10% of the reticular fiber
network is covered by either interdigitating DCs or macrophages to provide those
cells  with  the  molecules  transported  within  [172,  77].  The  reticular  fiber  network
doesn't seem to be exclusively bound to the lymph node, Nolte et al. suggest that it is
also abundant in the spleen where it fulfills similar tasks [172, 133]. To attract T-cells
and dendritic cells which move along the reticular fiber network, fibroblastic reticular
cells express CCL19, CCL21 (which both bind to their receptor CCR7 and CXCR4 on
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T-cells) and IL7 [5, 9, 87, 13, 200, 114, 109, 13, 10, 201, 26]. As mentioned above,
also dendritic cells move along the reticular network. After they enter the lymph node,
they move from the subcapsular sinus towards the parenchyma where they connect
to the reticular fiber network, to increase the odds to present a matching antigen to a
T-cell. After all, the dendritic cell movement along the stromal surface is dependent
on CLEC-2 binding to gp38 [26, 13, 162, 1, 2, 5]. By developing tubular and cysternic
intracellular structures, FRCs create a network of tunnels which is connected to the
conduit system and the abluminal cell  surface by numerous stomata, ensuring an
exchange between the conduit system and the interstitial space [5, 48]. FRCs which
verge on each other  are separated by space of  ca.  20nm. The intra-cytoplasmic
reticular system of these FRCs opens into this space via small orifices. The intra-
cytoplasmic reticular system is suspected to be closely linked to the conduit system.
FRCs  located  close  to  the  subcapsular  sinus  collect  antigen  as  well  as  lipids,
cytokines, neuropeptides, microbial  products and transport  it  through their conduit
towards high endothelial venules [5, 48, 8].  HEVs are usually surrounded by FRCs,
via CXCL12, CCL19 and CCL21, FRCs interact with lymphocytes that are located in
the vessel, triggering their migration through the HEV [48, 62, 44, 114, 10, 188, 167].
Some  FRCs  not  just  envelop  high  endothelial  venules  with  thin  cytoplasmatic
extensions and are connected to the reticular FRC network, but they also envelop
vessels of the fenestrated type in the medulla (see figure 1) [48]. Apart from that, they
also provide survival signals for T-lymphocytes and are able to present antigen in
respect of self tolerance and limit autoreactivity by T-lymphocytes, hence being of
utmost importance in immunologic events in contrast of former opinion [93, 98, 130,
67, 113, 43, 61]. FRCs are believed to origin from mesenchymal precursor cells [93].
Stromal cells in the immunological sense are all cells that are not of hematopoetic
origin and lack therefore exclusive leukocytic markers such as CD45. It is common to
subdivide the stromal cells in murine lymph node into four populations, even if a more
delicate  subdivision  is  possible,  but  in  case  of  our  studies  not  relevant.  The
classification into four specimens is made by the help of the two surface markers
CD31 and gp38. Both, blood endothelial cells, constructing ordinary blood vessels,
high endothelial venules and lymphatic endothelial cells express CD31 also known
as EndoCAM, whereas the double-negative fraction and FRCs are CD31 negative.
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On the other hand, podoplanin (gp38) is expressed by only lymphatic endothelial
cells  and  fibroblastic  reticular  cells,  while  double-negative  cells  as  their  name
suggests and blood endothelial cells do not [32]. FRCs are also in possession of the
intracellular marker ER-TR7 and CD140a [61], on which most of the authors are in
agreement, while other intracellular markers are in discussion, such as VEGF, NOS2,
IDO,  INOS  and  RANKL,  just  to  mention  a  selection  which  shows  that  FRC
classification is still far from finite classification [5, 87, 172, 100, 32, 62, 63, 110, 166,
106, 78]. The composition of the stromal compartment is, as this study also shows,
very dynamic. Fletcher at al. have shown that skin-draining and mesenteric lymph
nodes have a significantly different composition of stromal cells, for mesenteric lymph
nodes are less FRCs present than in skin-draining lymph nodes. In regard on the
other stromal subsets however, no differences have been found. MRCs on the other
hand appear in the FRC gate on flow cytometry also don't change in numbers making
the difference exclusively for FRCs [62]. Under physiological conditions, the classic
stromal cells, namely FRCs, LECs and BECs, carry Toll-like receptor 3 (TLR3) on
their membrane, a receptor which binds and reacts to double-stranded RNA as it
appears  in  many viruses,  making  it  possible  that  they are  able  to  react  to  viral
infection. TLR7 and TLR8 are not expressed by either FRCs and LECs or BECs [61,
194]. Pericytes lack podoplanin on their surface, which is a classical FRC marker.
They belong to the double negative cells. Marginal zone reticular cells in contrast do
express gp38. They can only be differed from FRCs by their expression of MadCAM-
1, CXCL13 and high levels of RANKL while FRCs in the T-cell-zone (TRCs) do not
express above molecules but are positive for CD157 [5, 166, 110, 101, 124, 78]. The
position of FDCs, who are resident in the B-cell-zone provide survival factors for B-
cells such as BAFF, also express gp38 however can be distinguished from FRCs by
their expression of CD35 [93, 16]. As mentioned above FRC and T-cell function are
closely linked together since both provide survival signals for each other. Viral loss of
FRCs also causes deterioration in antigen-specific T-cell priming and a loss in T-cells.
This is due to the lack of IL-7, CCL19 and CCL21, which are produced by fibroblastic
reticular cells to promote T-cell survival [5, 100, 160, 206, 26, 47]. Not only CD8+ T-
cells interact with FRCs, also CD4+ T-cells interact with FRCs via MHC class II, since
MHC II  is  produced by FRCs in  low levels.  The production  of  MHC II,  which  is
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dependent on the PIV promoter region of CIITA, is increased during inflammation.
Further  evidence  even  suggests  astonishingly,  that  MHC  class  II  can  even  be
transferred to fibroblastic reticular cells by dendritic cells via microsomes [26, 114,
56].  Apparently  impairment  of  autoreactive  T-cells  by  FRCs  is  also  happening
independently from antigen: freshly activated CD4+ and CD8+ T-cells are limited in
their expansion by fibroblastic reticular cells, however in order to do so, a cell-cell-
contact or at least aerial proximity between effector and receptor cells need to be
established. The suppressive effect by FRCs is carried by inducible NO synthase
(iNOS) [26, 106, 85, 166]. NO produced by fibroblastic reticular cells not only has
suppressive effect on T-cells, apparently it is responsible for the genesis of CD4+
CD25+ Foxp3- regulatory T-cells (Tregs). But in order to do so, dendritic cells have to
be present as depletion of DCs abolishes the ability of FRCs to induce Tregs [26, 2,
46, 131, 132]. It is believed that during inflammation stromal cells are recruited from
mesenchymal stem cells, although this has not been unequivocally proven yet. Other
than in steady state,  mesenchymal stem cells appear in the blood in an ongoing
inflammation  and  express  adhesion  molecules,  suggesting  that  they  are  able  to
migrate from their place of origin to their destination to further differentiate [93, 20,
111, 125, 169, 156]. Another idea is that the FRC precursors originate directly from
the  lymph  node,  since  there  are  also  mesenchymal  stromal  cells  present  under
physiological conditions [93, 169]. The last popular opinion includes the idea of stem
cell recruitment from surrounding fat tissue, as it is possible to gather mesenchymal
stromal cells from it, furthermore lymph nodes are usually embedded in fat tissue,
thus,  this  idea  has  to  be  considered  [93,  92, 144,  123,  21,  26].  The  following
differentiation of the mesenchymal stromal cells towards stromal cells triggered by
lymphotoxin and TNF alpha is discussed in the field and remain to be elucidated in
the future. [93, 138].
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Figure 1: Display of lymph node structure via light microscopy: 1996, Crivellato et al. produced
these light microscope images of lymph nodes. The samples have been fixated by using the zinc
iodide-osmium method and are stained with toulidine blue. The bar represents a length of 15µm. FRCs
can be identified in these exposures by their dark-grey coloring. These exposures show that FRCs
which are resident in the medulla are of a stellate structure and posses 1 or 2 oval nuclei. The vessels
(asterisk)  shown  in  a)  are  ensheathed  by  FRC membranes,  these  membranes  however  do  not
ensheath the endothel cells continuously, creating a fenestrated hull for the vessel. Also fenestrated
vessels  (asterisk) are enveloped by cytoplasmic processes of  FRCs (see b)).  Next  to fenestrated
vessels, also high endothelial venules (asterisk) are wrapped by FRC structures (see c)).
(Figure by Crivellato et al. [48], rearranged by Niklas Klein)
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Figure 2: The three dimensional display of the conduit system of FRCs: This figure by Sixt et al.
gives an excellent insight about how the reticular fiber network, or conduit system, looks like. It is a
three dimensional reconstruction of an immune histochemical staining. The size bars measure 1µm. a)
Shows a fiber in which 40kDa FITC-DEX (green) has been injected. One can clearly see that the
lumen  of  the  conduit  is  wrapped  by  the  basement  membrane  molecule  perlecan  (red).  The
magnification box shows that perlecan does not overlap FITC-DEX, the red line marks the same static
point in the upper and lower magnificated box. b) Shows a staining of pan-laminin and collagen 1
where  one  can  see  that  the  collagen  1  is  surrounded by laminin.  c)  d)  Also  ER-TR7 antigen  is
ensheathing collagen 1. e) Reticular fibroblasts which express smooth muscle actin (SMA) wrap the
basement  membrane.  f)  Represents  a  double-staining  for  ER-TR7  and  SMA.  g)  Reviews  which
molecules are present in which part of the reticular fiber network. 
(Figure by Sixt et al. [172], rearranged by Niklas Klein.)
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3.1.2 Characterization of lymphatic endothelial cells 
Lymphatic endothelial cells, as their name suggests, build the lymphatic vessels, they
origin from blood endothelial  cells [195].  The vessels built  by LECs transport  the
lymph fluid  towards the  lymph node and there the  lymph fluid  is  spilled into  the
parenchyma,  where  it  travels  through  the  lymph  node  to  reach  again  efferent
lymphatic vessels in the medulla after the lymph fluid has been filtered through the
paracortex  and  cortex  [62,  117,  196].  Lymphatic  endothelial  cells  are  not  just
responsible for the transport of antigen towards the lymph node, they even seem to
be able to enrich antigen under inflammatory conditions [32, 177]. CD31, EndoCAM
or PECAM-1 is expressed not just on endothelial cells such as blood endothel or
lymphatic  endothel,  but  also  on  some  macrophage  subsets,  granulocytes  and
platelets.  It  is  thought  to  be  crucial  for  angiogenesis,  intercellular  connections
between endothelial cells and activation of leukocytic transendothelial migration [99].
Lymphatic endothelial cells have a special feature that is unique among all  lymph
node stromal cells: Those cells are the only stromal cells within the lymph node that
express the melanocyte-associated enzyme tyrosinase. This is of high importance as
this peripheral tissue antigen is recognized by certain T-cells which then have to go
into apoptosis in order to prevent auto-immunity [61].
3.1.3 Characterization of blood endothelial cells
Blood endothelial cells (BECs), build up blood vessels and capillaries to which also
high  endothelial  venules  (HEV)  belong  that  are  specialized  on  the  attraction  of
circulating naive T-cells and other immune cells [62, 117,  196]. In this work, blood
endothelial  cells  present  in  the lymph node are characterized by the absence of
CD45 and gp38 and presence of CD31.
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3.2 Leptin and its receptors
3.2.1 Characterization of leptin
Leptin is a 16kDa heavy peptide hormone. It is mainly secreted by white adipocyte
tissue and is most commonly known for its effects on the feeling of satiety, which
takes place mostly but not exclusively in the hypothalamical region. Leptin is linked to
secretion of  hormones of  the hypothalamus-hypophysis-adrenal  axis.  Moreover,  it
influences the reproductional behavior, angiogenesis, the hematopoetic system and
also regulates the energy household through lipid and glucose metabolism [139,  74,
187,  52,  53, 202, 178, 64, 36,  168,  22].  Next  to  white  adipocytes,  leptin  is  also
expressed in  various other  tissues,  for  instance lymphatic  tissues,  female  sexual
organs, such as placenta and ovary, but also in the pituary gland, skeletal muscle
and  immune  cells,  e.g.  regulatory  T-cells  (Treg).  As  mentioned  before,  the
hypothalamic region plays a crucial role in leptin signaling as leptin and its receptor
are  also  expressed  in  this  location,  especially  in  the  arcuate  nucleus  and
ventrolateral hypothalamus where inhibition of fooduptake is mediated [139, 51, 202,
146, 145, 154]. The leptin level in blood is not constant, as it succumbs not just to a
circadian rhythm, but is also dependent on other factors. It is secreted in a pulsatile
mode influenced by calorie intake, namely high circulating leptin level in the condition
of obesity and low levels in case of starvation. It also correlates in a linear manner
with the amount of body fat [139,  50], as well as the gender: Levels of circulating
leptin are higher in women [197, 76, 118]. Next to that, leptin levels are also changed
under  certain  pathological  conditions,  such  as  reproductive  diseases  [39]  and
cardiovascular diseases [173, 193, 198, 150]. However, a high leptin level should
result in a lower weight as its task is the reduction of food intake. However in obesity,
higher leptin plasma levels over time lead to resistance against leptin. Various factors
have  been  suspected  to  be  in  charge  for  central  leptin  resistance:  The  ongoing
inflammation in obese individuals most certainly plays a crucial role, next to general
factors such as autophagy and endoplasmic reticulum stress. Besides the disturbed
leptin signaling in the hypothalamus mediated by inhibition via SOCS3 and PTP1B,
there is an overall inhibition of the passage of leptin across the blood-brain barrier.
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Moreover, there is a dysfunction in the skeletal muscle mitochondria that results the
accumulation of lipids in the sceletal muscle cell. Normally, leptin has the ability to
decrease the intramyocellular lipid level by induction of the mitochondrial fatty acid β-
oxidation,  in  which  skeletal  muscle  5'adenosin  monophosphate-activated  protein
kinase (AMPK) is believed to play a crucial role [139, 121, 128, 83,  178,  190, 165,
126, 75]. In contrast, Tanaka et al. generated transgenic skinny mice overexpressing
leptin in the liver, which results in a high plasma leptin level that resembles obese
humans. However, as in obese humans or mice with diet induced obesity (DIO), the
leptin tolerance increases.  This does not happen in the transgenic mice in which
leptin  stays  metabolically  active.  Furthermore  Tanaka  et  al.  state  that  transgenic
skinny mice have an increased sensitivity towards leptin, which augments skeletal
muscle and liver insulin receptor signaling caused by chronic activity of AMPK, and
thereby  enhanced  phosphorylation  of  acetyl  CoA carboxylase  (ACC)  a  target  of
AMPK, in skeletal muscle [178]. This provides a protective effect against diabetes
according to Masuzaki et al. who hybridised transgenic skinny mice overexpressing
leptin  (Tg/+)  with  lethal  yellow KKAy mice  (Ay/+),  an  obesity-diabetes  syndrome
model. Six weeks after birth, Tg/+:Ay/+ mice showed higher plasma leptin levels than
Ay/+, also insulin sensitivity and glucose tolerance was higher in the Tg/+:Ay/+ mice
than in the Ay/+ mice. However, according to Masuzaki et al., the weight of the mice
did not differ significantly between the models and compared to wild type mice. Yet at
the age of 12 weeks, Tg/+:Ay/+ the mice's leptin level dropped to the level of that of
Ay/+  mice  and  subsequently  the  Tg/+:Ay+  mice  suffered  from  obesity-diabetes
syndrome. Both groups then received a three-week food restriction treatment. The
leptin level in Tg/+:Ay/+ mice however exceeded that of Ay/+ mice but dropped in Ay/
+ mice and wild type mice. Interestingly, the weight, insulin sensitivity and glucose
tolerance recovered in the Tg/+:Ay+ model, showing that higher leptin levels also
during food restriction help to recover from diabetes  [115]. Furthermore, transgenic
skinny mice without the Ay allele lose their lean, insuline sensitive phenotype when
being fed a high fat diet. When regaining the common diet, the transgenic skinny
mice  reduced  their  weight  faster  than  their  wildtype  counterparts,  and  also  their
sensitivity for insulin recovered quickly. Tanaka et al. attribute this effect to the quick
regeneration of leptin sensitivity [178]. Next to calorie intake, different hormones have
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an  impact  on  leptin  expression:  Catecholamines  reduce  the  leptin  level,  while
hormones such as glucocorticoids, insulin and pro-inflammatory cytokines stimulate
the production of leptin [139, 4]. As mentioned above, females tend to have a higher
level of circulating leptin than males, which may be caused by the higher quantity of
female subcutaneous fat tissue. Additionally, estrogen and testosterone support this
dimorphism, as testosterone lowers the leptin expression, while estrogen stimulates
the production of leptin. Because of this, only female mice have been used in the
process of  the experiments [139,  121].  Experiments with  leptin  deficient  or  leptin
receptor deficient mice show the importance of leptin as mice being subject to these
conditions suffer from severe obesity,  infertility and diminished linear growth as a
consequence  of  missing  leptin  signaling  triggered  hyperphagia  [139,  90].  As
mentioned further above, leptin signaling has also a huge impact on the immune
system.  In  both,  the  adaptive  and the  innate  immune system,  various cell  types
express the receptor  for  leptin  and are directly influenced by that  hormone.  Both
major T-cell populations, the CD4+ and the CD8+, carry LepR in their membrane.
The function of  leptin  on  CD8+ T cells,  apart  from a publication  by Chen et.  al.
demonstrating  an  effect  of  leptin  on  T  cell  maintenance  [37],  remains  poorly
understood until today. On the other hand, their CD4+ counterpart is well researched.
CD4+ T-cells express the long isoform of the leptin receptor. The binding of leptin on
murine T-cells enhances proliferation via IL-2 mediated by MAPK and PI3K pathway
and  survival  via  enhancing  the  presence  of  GLUT1  and  GLUT4  in  the  T-cell's
membrane. Additionally, the migration mediated by ICAM-1 and very late antigen 2
(VLA2) is enhanced [146, 104, 105, 137, 171]. Also T-cell differentiation is affected by
leptin,  as  ob/ob  mice  showed  impaired  development  from  naive  T-cells  towards
helper cells compared to wild type mice. This could be attributed to lower amount of
GATA-3 and T-bet, which are transcription factors for the differentiation to TH1 and
TH2 helper cells [146, 19]. On regulatory T-cells, an inhibitory effect of leptin on their
proliferation has been shown. Their frequencies are higher in both, ob/ob mice and
db/db mice. mTOR plays a crucial role in this, as impairment of this pathway leads to
increased  numbers  of  Tregs  in  db/db  mice  [146, 147, 154].  In  contrast,  leptin
promotes proliferation of  TH17-cells.  Mice with  impaired leptin  signaling,  such as
leptin or leptin receptor deficiency or obese mice, show a reduced frequency of TH17
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cells. The low TH17 count can be compensated by exogenous leptin supply at least
in obese mice [146, 151]. When looking at lymphocytes, leptin is not only a crucial
participant  in  T-cell  homeostasis,  but  also  in  the  function  of  B-lymphocytes.  A
significant loss of B-cells and their precursors occurs in obese mice suffering from
leptin deficiency. However a substitution of leptin over seven days could raise again
the  count  of  B-cells  in  the  bone  marrow.  Tanaka  et  al.  performed  a  starvation
experiment  which  showed that  also in starving mice B-cells  were  reduced in  the
same manner and that replenishment of leptin could prevented the B-cell drop [146,
41, 179]. Leptin prevents B-cell apoptosis by activation of B-cell CLL/lymphoma 2
(Bcl-2) and cyclin D1 causing cell cycle entry [146, 95]. Also cytokine secretion by B-
cells is enhanced by leptin, such as IL-10, IL-6 and TNF-alpha. The boosted cytokine
secretion  is  a  result  of  the  activation  of  STAT2/STAT3  and  p38MAPK/ERK1/2
signaling cascade [146, 3]. When it comes to the innate immune system, leptin plays
a key role as well.  It  influences the major key actors of innate immunity,  such as
macrophages, neutrophil, eosinophil, as well as basophil granulocytes, dendritic cells
and  natural  killer  cells  [146].  First  of  all,  the  major  phagocytic  cell  type,  the
marophages: Relatively early it became obvious that leptin is linked to these myeloid
cells.  Leptin  deficiency  leads  to  impaired  ability  to  phagocytosis  or  excretion  of
inflammatory cytokines, whose excretion relates positively with the concentration of
leptin. Accordingly, substitution of the peptide hormon reverses the impairing effect
[146, 103, 66]. Moreover, activation, proliferation and migration of macrophages are
regulated by leptin. Various surface molecules such as HLA-DR, CD11b and CD11c
are upregulated and leptin serves as strong chemoattractant. The homing properties
of leptin however are strictly linked to the presence of the long isoform leptin receptor
on macrophages. As mentioned above, even macrophage phagocytosis is linked with
leptin  signaling. Gruen  et  al.  demonstrated  in  mice  that  leptin  causes  enhanced
calcium influx into the cell, resulting in the activation of JAK/STAT, MAPK and PI3K
pathways  which  influence  the  macrophages'  motility  [146,  159,  72].  Next  to
macrophages, neutrophil granulocytes are also affected by leptin. They only express
the short isoform of the leptin receptor and its activation results in the expression of
CD11b  and  inhibition  of  apoptosis  by  impairment  of  mitochondrial  cytochrome  c
release as well as the inhibition of caspase-3 and caspase-8, thus giving hints that
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also the short isoform leptin receptor can mediate regulatory effects [146, 27, 205]. At
least in humans, leptin enhances the intracellular hydrogen peroxidase resulting in a
regulation  of  ROS  production  [146,  29].  Like  in  macrophages,  leptin  promotes
phagocytosis also in case of neutrophils, as the ability to phagocyte klebsiella was
impaired in ob/ob mice. [146, 122]. Also the granulocytic siblings of the neutrophil
granulocyte, the eosinophil granulocytes succumb the influence of leptin signaling in
a similar manner. Also in this case leptin impairs mitochondrial cytochrome c release
and cleavage of Bax protein. Alike its influence on neutrophil granulocytes' surface
proteins, leptin promotes the expression of several surface molecules such as CD18
and  ICAM-1,  however  lowers  the  expression  of  L-selectin  and  ICAM-3.  Another
parallel  to  neutrophil  granulocytes is  the regulation of  eosinophil  cell  migration in
humans. Leptin enhances the secretion of inflammatory chemokines (e.g. monocyte
chemotactic protein-1 and growth-related oncogene-alpha) and cytokines, such as
IL-1beta and IL6 [146, 45, 199]. Different from neutrophil signaling, leptin in human
eosinophil granulocytes is accountable for the fast phosphorylation of p38 MAPK and
extracellular signal-regulated kinases 1/2 (ERK1/2), but seemingly does not influence
the calcium household [146, 89]. Next to the already presented cells, there are the
dendritic cells which are also regulated by leptin signaling. Dendritic cells are less
potent antigen presenters and also their frequencies differ in leptin deficient animals
compared to wild type controls [146, 112]
3.2.2 Characterization of the leptin receptor and signaling
The leptin receptor (LepR or OB-R) has various splice isoforms. LepR is counted to
the class 1 cytokine receptor family and the signaling pathway is often mediated by
janus  kinases  (JAKs)  and  so  called  “signal  transducers  and  activators  of
transcription“  (STAT)  [65].  LepR is  mainly  expressed  in  the  brain,  especially  the
hypothalamical  region,  where  it  triggers,  as mentioned already above,  anti-obese
effects [139, 74]. Next to the brain, there are various other tissues and cells that bear
the leptin receptor, for example on several immune cells [146, 145] and, as our work
group showed, on fibroblastic  reticular cells  (see 5.2.1).  The gene that  codes for
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these receptors, the OB-R gene, contains enough genetical information to provide
the organism with at least five alternatively spliced isoforms (Ob-Ra, Ob-Rb, Ob-Rc,
Ob-Rd, Ob-Re) [64,  180, 97]. Also a soluble isoform of LepR is described [94, 97].
Many sources state that only the long isoform, OB-Rb, is functional. However, several
sources attribute a functionality also to short isoforms. Bruno et al. showed in their
experiments with neutrophils, which only bear the short isoform of the leptin receptor,
that  leptin  is able to  trigger  the JAK2/MAPK and the PI3K pathway and an anti-
apoptotic effect in neutrophils. OB-Rb is the longest possible peptide chain translated
by  this  gene  and  triggers  pathways  like  JAK2/STAT3  and  STAT5,  AMPK/ACC,
IRS/PI3K,  SHP2/MAPK and  SOCS3 [65, 139, 27].  Figure  3  gives  an  exemplary
depiction  of leptin/LepR singaling  pathway. SOCS3 mediates  an  inhibition  of  the
JAK2/STAT3  pathway  and  thereby  creates  a  negative  feedback  loop.  Next  to
SOCS3, also protein tyrosine phosphatase 1B (PTP1B) is involved in the inhibition of
leptin  signaling  via  dephosphorylation  of  phosphorylated  JAK2  [139,  50,  121].
Usually, binding of leptin to its receptor, especially the long isoform LepRb, leads to a
dimerization of the receptor. Thereafter the receptor dimer forms a complex with the
Janus  kinase  2  (LepRb/JAK2  complex)  thus  activating  JAK2,  which  then
phosphorylates itself and tyrosine molecules (Tyr 985, Tyr1007 and Tyr 1138) of the
receptor dimer. Phospho-Tyr 1007 and phospho-Tyr 1138 again activate STAT3 and
STAT5 by binding to it  and phosphorylating it  (phospho-Tyr  1007 binds to STAT3
andphospho-Tyr1138 binds to STAT5). So being phosphorylated, STAT3 and STAT5
move into the nucleus and follow their task as transcription factors. As mentioned
before, a negative feedback mechanism is induced by SOCS3, as it is a product of
the gene targeted by STAT3. Next to SOCS3, protein tyrosine phosphatase 1B is
also  a  inhibitor  of  the  signal  cascade.  The  inhibitory  effect  is  mediated  by
dephosphorylation of JAK2. However when JAK2 is phosphorylated, it induces the
binding  of  SH2-containing  protein  tyrosine  phosphatase  (SHP2)  and  phopsho-
Tyr985, which activate the adaptor protein growth factor receptor-bound protein 2
(Grb2).  Grb2  can  now  activate  the  mitogen-activated  protein  kinase  (MAPK).
However,  leptin-activated JAK2 is able to cut short  the SHP2 cascade by directly
activating MAPK. Another pathway induced by JAK2 is the downstream activation of
phosphatidylinositol  3  kinase  (PI3K)  by  phosphorylated  insulin  receptor  substrate
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(IRS). PI3K again will activate forkhead box O1 (FoxO1) (not shown in the figure),
mammalian target of rapamycin (mTOR) and phopshodiesterase 3B (PDE3B) [139].
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Figure 3: Exemplary depiction of the leptin/LepR singaling pathway:  This figure by Park et al.,
gives a  sublime overview about the signaling pathway of  leptin binding to the long isoform of  its
receptor LepRb. When leptin binds to its receptor,  two receptors form a dimer and configure to a
complex with the Janus kinase 2 (LepRb/JAK2 complex), thereby activating Janus kinase 2 which
subsequently phosphorylates not just itself, but also amino acids of the leptin receptor, namely Tyr985,
Tyr1077 and Tyr1138. Phospho-Tyr 1138 and phospho-Tyr1077 are now bound by STAT3 and STAT5,
which are again phosphorylated and therefore activated. Both STAT3 and STAT5 now shift to the cell
core to initiate the transcription of their targeted genes. A negative feedback loop is created by the
activation  of  SOCS3,  which  is  also  a  target  gene  of  STAT3,  by  phospho-Tyr985.  It  inhibits  the
JAK2/STAT3  pathway.  Another  inhibitor  of  the  leptin  signaling  pathway  is  the  protein  tyrosine
phosphatase 1B (PTP1B),  it  deploys its inhibitory effect  by the dephosphorylation of  JAK2. When
JAK2 gets activated, SH2-containing protein tyrosin phosphatase 2 (SHP2) binds to phospho-Tyr985
of the LepRb, thus activating the adaptor protein growth factor receptor-bound protein 2 (Grb2), which
again activates the mitogen-activated protein kinase (MAPK)  signaling cascade. Independently from
SHP2, MAPK is activated by leptin via JAK2. Furthermore it activates the phosphatidylinositol 3 kinase
(PI3K) via a phosphorylation of insulin receptor substrate (IRS) which is again activated by JAK2. The
targets  of  PI3K  are  forkhead  box  O1  (FoxO1),  mammalian  target  of  rapamycin  (mTOR),  and
phosphodiesterase 3B (PDE3B).  5'adenosin  monophosphate-activated protein  kinase (AMPK) and
acetyl-CoA carboxylase (ACC) regulate the metabolism and the feeling of satiety [139].
(Figure by Park et al. [139]).
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4. Materials and Methods
4.1 Solutions, reagents and materials
Solutions and reagents that have been used are shown in table 1.
Table 1: Solutions and reagents: This table shows the solutions and reagents used in the experiments,
as well as their suppliers.
Cell culture and flow cytometry
Reagent Concentration Supplier
RPMI Culture Medium Life technologies
Dulbecco’s Phosphate Buffered 
Saline
Sigma Life Science
Hank's Balanced Salt Solution Sigma
EDTA 0,5M pH 7,4 0,5M Sigma
UltraPure EDTA 0,5M Life technologies
Trypsin Life technology
Heat Inactivated FBS Life technologies
Penicillin/Streptomycin Life technology
ACK Lysing Buffer Life technologies
FACS-Buffer Miltenyi Biotec
MACSquant Running Buffer Miltenyi Biotec
AutoMACS Rinsing Buffer Miltenyi Biotec
AutoMACS Running Buffer Miltenyi Biotec
Collagenase P 100mg/ml Roche
Dispase 100mg/ml Roche




PI (Propidium Iodide) Miltenyi Biotech
Ter119 antibody PeCy7 0,2mg/ml Biolegend
CD45 antibody APC-Cy7 0,2mg/ml Biolegend
gp38 antibody APC Biolegend
CD31 antibody FITC 0,5mg/ml BioLegend
Anti-goat antibody FITC Life technologies
CD3e antibody A488 0,5mg/ml BioLegend
CD19 antibody PE 02,mg/ml BioLegend
CD11c antibody APC 0,2mg/ml BioLegend
CD11b antibody PeCy7 0,2mg/ml BioLegend
CD103 antibody PE 0,2mg/ml BioLegend
CD35 antibody biotinylated 0,5mg/ml Biosciences
Streptavidin PeCy7 0,2mg/ml BioLegend
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Streptavidin 405 1mg/ml Life technologies
Goat IgG Biotechne
Hamster IgG PE 0,2mg/ml BioLegend
Rat IgG 2aƙ PE Biolegend
Rat IgG 2bƙ PeCy7 0,5mg/ml BioLegemd
Armenian hamster IgG APC 0,2mg/dl BioLegend
Armenian hamster IgG PE Biolegend






cybergreen fast Life technologies
cybergreen save Life technologies
Agarose Biozym scientific
Col1 primer Thermo Fisher Scientific
CXCL-10 primer Thermo Fisher Scientific
FLT-3 primer Thermo Fisher Scientific
MCSF primer Thermo Fisher Scientific
MMP2 primer Thermo Fisher Scientific
MMP9 primer Thermo Fisher Scientific
NOS-2 primer Thermo Fisher Scientific
SMA primer Thermo Fisher Scientific
TGF-β primer Thermo Fisher Scientific





RIPA-buffer Thermo Fisher Scientific









Pre stained dual color marker Bio-Rad
Laemmli buffer Bio-Rad
Leptin  receptor  antibody  rabbit
Western Blot
10mg/ml Abcam




To research basic functions of stromal cells, the use of a cell culture is essential. In
this thesis several cell lines were utilized: FRC-T, FRC-TN, FRC-2 (FRCs of spleenic
origin) and a bone marrow FRC cell line, namely CRL-2648™ by ATCC®, Manassas,
Virginia,  United  States  of  America.  After  thawing,  the  cells  are  cultured,  if  not
specified otherwise in  a  RPMI +  10% FBS + 1% Penicillin/Streptomycin  medium
(13ml in a cell  culture flask with an cultivated area of 25 cm² and 25ml in a cell
culture flask with a cultivated area of 175cm²). They are sterilely processed and kept
at  37°C  in  a  humidified  incubator.  Medium  is  changed  every  three  days.  After
discarding the old medium, a flushing with PBS and then replacement of nutritional
medium in the same concentration as mentioned above followed (see figure 4). Cell
culture is monitored by light microscope in 40x magnification, regarding the shape of
the  cells,  the  density  of  their  growth  and  amount  of  debris  surrounding  them.  If
required, cells are splitted and expanded. For this, the culture medium is taken away,
the adherent cells are washed with PBS and were incubated for 2min at 37°C in 2 ml
0,05%  trypsine  solution,  which  will  lyse  adherent  molecules.  At  the  end  of  the
incubation time, digestive function of trypsine is slowed down by diluting it with 8 ml
RPMI and the sample is transferred into a 15ml tube which will be centrifuged (300g
5min 20°C). Supernatant will be discarded and the pallet will be resuspended in 13
ml medium and put back into a culture bottle. When cells are ready grown, they are
harvested by first flushing them with PBS, then incubated in 5mM EDTA at 37°C until
a single cell suspension is reached, if necessary, a cell scraper is used. The cells
were monitored with light microscope.
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4.2.2 Primary cell culture
4.2.2.1 Isolation of primary cells from mice
Mice were kept according to the regulations of the Landesamt für Verbraucherschutz,
Saarbrücken Germany and are fostered under pathogen free conditions in a mouse
cabinet. Mice were purchased from Charles River (Sulzfeld Germany). The animals
were anesthetized with isoflurane and cervical dislocation was performed. Mice are
dissected  via  median  incision  of  the  abdominal  and thoracal  skin,  followed  by a
double T-cut to its extremities,  then moving the skin flaps to the sides and fixed,
which will reveal the inguinal, axillary and brachial subcutaneous lymph nodes which
are used for the experiments. Lymph nodes are taken out with forceps and put in
PBS on ice, adherent fat and other connective tissue is detached mechanically. To
dissolve the lymph nodes the following protocol is used. When transferring into a
15ml  Falcon  Tube,  the  lymph  nodes  are  crushed  with  a  forceps  to  weaken  the
connective tissues of the lymph node. Now the lymph nodes are incubated in 1600µl
of digestion buffer (50ml RPMI +100µl Collagenase C +100µl DNAse +400µl Dispase
+5ml FBS) on 37°C in a water bath. In the first 10min, the sample will be shaken
gently every 5min to ensure that the lymph nodes do not accumulate. On time mark
15min, the sample is resuspended by the help of a 1000µl pipette with its pipette tip
cut  off  to  mechanically  dissolve  the  target.  After  additional  7,5min,  this  step  is
repeated.  However  supernatant,  which  contains  the  dissociated  cells,  will  be
collected and stored on ice. This step is now repeated every 7,5min but with an uncut
pipette tip until time mark 45min, where the interval between the steps is reduced to
5min.  After  every  second  uptake  of  supernatant,  the  collected  supernatant  is
centrifuged (1300g, 4min, 4°C), subsequently the supernatant is discarded and the
pellet is filtered (100µm) and resuspended in collection buffer, consisting of RPMI +
1% FBS and 2mM EDTA. Digest is ceased when no particulate matter is left in the
tube, latest after 90min of digest. Now the cells can be further processed to either
flow cytometry analysis or cell culture.
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4.2.2.2 Setup of a primary culture of lymph node stromal cells
In order to investigate further the fibroblastic reticular cells, the establishment of a
primary cell culture was necessary. To do so, cells were isolated from C57BL/6J mice
according to a previously published protocol [106]. Purified sample from lymph node
digest is centrifuged (300g 5min 20°C) and resuspended in 2ml*number of wells in
which cells are kept RPMI +10%FBS +1%P/S. 10^7 cells are assigned to one well of
a six well plate, afterwards the cells are given 24h to rest. Now the cell medium is
taken away and they are flushed strongly three times with 2 ml PBS, subsequently
medium will  be renewed. This is to make sure that non-adherent cells, namely T-
cells,  B-cells  and  erythrocytes  are  discarded  from  the  culture.  Adjacent  further
manipulation is ceased but change of nutrition medium is necessary until the cells
are grown dense (see figure 4).  This  will  ensure  that  double-negative  and blood
endothelial  cells  are  absent  and  only  macrophages,  dendritic  cells,  lymphatic




Figure 4: Washing of a cell culture: In order to cultivate a cell line and to ensure proper growth, the
cells have to be washed periodically every three days. To do so, the culture dishes/ culture flasks are
transported to a workbench where the work happens under sterile conditions. Before the first step, the
culture plates or flasks are observed by the help of a microscope to ensure that the culture has not
grown too densely. After placing the culture in the sterile working bench, all supernatant is taken off
and discarded. If this happened, the discarded volume is replaced by 5 ml PBS. The culture dish/
culture flask will  now be slewed gently a few times, then the supernatant  is  discarded. This step
happens three times. After the last run, the initial volume of nutrition medium will be filled up again and
the cells are brought back into the incubator.
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4.3 Flow cytometry
To characterize cells by their size, their granulation and most important their surface
and  intracellular  molecules,  in  this  experiment  flow  cytometry  was  used  (MACS
Quant 10 Analyzer (Miltenyi)). Flow cytometry is a technique whose key instruments
are white light and lasers of different wavelength, which, in case of the laser, activate
the fluorochrome linked to the antibody. A blue laser (488nm) rays the cell and the
deflected light is collected as forward scatter and sideward scatter. A high signal in
the forward scatter will be caused by a bigger cell volume. Whereas high granulation
of a cell will result in more dispersion of light, which is recognized by the sideward
scatter. With its three lasers and eight filters, MACS Quant 10 Analyzer is capable of
distinguishing between eight fluorescence channels additionally to the forward and
sideward  scatter  (figure  8).  Produced  data  was  analyzed  by  using  the  software
FlowJo  10.0.6  (Ashland,  Oregon,  USA).  When  gating  the  cell  population,  the
procedure according to 5.1.1 was used.
4.4 Magnetic cell sorting
As there are multiple cell subsets left in a primary culture of lymph node stromal cells,
obsolete cells are sorted out via  magnetic cell  sorting (MACS). This technique is
based on antibodies linked to magnetic beads which will provide that the cells bound
to those antibodies will stick in a magnetic field and can be released and thereby
collected after turning off the magnetic field. In general there are two possibilities to
magnetic sort of cells, the positve and negative MACS separation. In negative MACS
separation, unwanted cells are bound to the magnetic beads and the flow through
contains the targeted cells. In positive MACS separation, targeted cells are bound to
magnetic beads and the first flow through is discarded, after moving the column out
of the magnetic field, the flow-through with its containing cells is collected. Figure 5
complements the protocol. First of all, the sample is centrifuged (300g 5min 4°C),
then the pellet is resuspended in 2ml MACS-buffer. Following the cells are counted
via flow cytometry and again centrifuged (300g 5min 4°C). If done so, staining for
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3*10^6 cells is as follows: Primary step consists of blocking of any Fc-Receptor with
re-suspension in 290µl MACS-buffer + 10µl Fc-Block, which will be incubated on ice.
After 5min 3µl of CD 45 biotinylated antibody and 6µl of CD 31 biotinylated antibody
is  given  to  the  sample,  which  will  now  rest  10min  on  ice.  Now  the  magnetic
microbeads are given to the sample, in with 160µl MACS-buffer and 15µl anti-biotin-
beads. Again the sample has to be incubated for 15min at 4°C. At time mark 7min the
sample is gently mixed by shaking the tube. When 15min are over, the sample is
filled up with MACS-buffer to a total sample volume of 5ml, and spinned down at
300g for 10min. Supernatant is taken away and the pellet is resuspended in 500µl
MACS-buffer, the sample is now ready for MACS separation. In order to do so, the
MACS device has to be installed (see figure 5). The column is prepared by attaching
a 100µm filter to it after placing it in the magnetic field. To ensure that the inner part
of the column is all wet, it is flushed with 3ml MACS-buffer. Finally the sample can be
loaded on the column, which is now flushed with 3*3ml MACS-buffer, however it has
to  be  taken  care  that  the  column must  not  run  dry.  In  case  of  negative  MACS
separation, which is the case in the current work, target cells pass the column, and
are collected in a tube. If aiming for positive MACS separation, it is necessary that
the column is now moved out of the magnetic field and eluted with 5ml MACS-buffer.
Target  cells  are  now  centrifuged  (300g,  4min,  4°C),  counted  and  can  now  be
cultured. It is inevitable to let the cells rest for 24h and control their morphology via
microscopy to control of the cell viability.
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Figure 5: Principle of magnetic cell sorting: In this illustration, the principle of magnetic cell sorting
is displayed in a highly simplified manner. After marking a certain cell population with magnetic beads,
the sorting process may commence. Whether the target cells are marked or not is dependend on the
general circumstances, e.g. the ratio between cell populations, the number of different populations in
the probe, or even the availability of bead conjugated antibodies, in general it is possible to enrich the
target cells by marking non-target cells. a) Shows the flow-through in a magnet field. The cells bound
to magnetic beads conjugated antibodies will stick to metal spheres inside the column (not shown for
simplification reasons) which are magnetized. Unmarked cells will be flushed out by the buffer flowing
through the column, these cells can either be collected or discarded. b) When the column is taken out
of the magnetic field, the metal spheres will lose their electromagnetic charge, releasing the magnetic-
bead-antibody-cell-complex.  These  complexes  can  now  be  flushed  out  with  buffer  and,  as  the
unmarked cells, either be collected or discarded. Due to further dilution of the cells in the process of
culturing, the magnetic-bead-antibody-cell-complex dissolves and the cells are not inhibited in their
growing behavior. However this whole process is extremely stressful for cells, so that a successful
cultivation is not guaranteed.
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4.5 Preparation of blood samples
To collect blood, the heart is punctured with a syringe from its apex towards the right
atrium as fast as possible after sacrificing the mice to ensure that the blood is not
already  coagulating.  400µl  blood  are  carefully  removed.  After  30min  at  room
temperature the sample is centrifuged for 15min at 1500g at 4°C. When collecting
serum, the supernatant can be carefully taken away and stored at -80°C.
4.6 Isolation of RNA 
In order to generate cDNA that can be used to perform a PCR, the first step is to
isolate the RNA from the cell population of interest. To do so, the Rneasy Plus Mini
Kit  by Qiagen has been used according  to  manufactural  guidelines  (Qiagen).  As
requested in the manual, after harvesting the cells, a maximum of 10^7 cells has
been used per isolation. As the cell number was always lower than 5*10^6, 350µl of
Buffer RLT Plus has been added to the tube after disrupting the cells. After doing so,
the solution has been decanted to a gDNA Eliminator spin column which is placed
inside a 2ml collection tube. The sample is now centrifuged for 30s at 3000g, during
the centrifugation, the sample will pass the Eliminator spin column and accumulates
in the collection tube, the Eliminator spin column may now be discarded. 350µl of
70% ethanol is now added to the flow-through and resuspended. The sample is now
filled into a RNeasy spin column, which again is placed in a 2ml collection tube. The
tubes are now centrifuged at 8000g for 15s. The flow-through has to be discarded. A
volume of 700µl Buffer RW1 is added to the spin column, still placed inside of a 2ml
collection  tube,  the  centrifugation  is  repeated  at  8000g  for  15s,  again,  the  flow-
through is to be discarded. Now a volume of 500µl Buffer RPE is added to the spin
column which has to be centrifuged with the same parameters as in the previous
step, the flow-through is to be discarded. After this step, the same amount of Buffer
RPE is added to the sample, this time however, the centrifugation is performed at
10000g for 2min. The spin column is now transferred to a 1,5ml collection tube and
30µl Rnase-free water is added on the spin column membrane without touching any
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surroundings or the membrane with the pipette tip. The tube is again centrifuged at
8000g for 1min. After centrifugation, the RNA is inside of the 1,5ml collection tube.
4.7 Production of cDNA
Generating  cDNA is  a  crucial  step  in  the  process  of preparing  a  PCR.  For  this
process, the QuantiNova Reverse Transcription Kit by Qiagen has been used. The
method of  operation is  similar  to  that  of  retroviruses or  hepadnaviruses,  the  key
enzyme is reverse transcriptase. In order to transcribe RNA to cDNA, the reverse
transcriptase  needs  two  functions:  First  of  all  the  ability  of  DNA-polymerase  to
synthesize  complementary  DNA,  and  second,  the  ability  of  RNAse-H  which
degradates the remaining RNA to oligonucleotides, so that the DNA-polymerase can
again synthesize a complementary DNA-strand [149]. To start the process, the RNA
samples, the gDNA removal mix and Reverse Transcription Enzyme is thawed on ice,
while  the  Reverse  Transcription  mix  and  RNase-free  water  is  thawed  at  room
temperature.  To  remove  possibly  remaining  genomic  DNA,  in  the  next  step,  the
genomic DNA removal reagent is prepared. To do so, 2µl of gDNA removal mix is
added to a sample volume up to 5µg of RNA, then, 1µl of Internal Control RNA is
added. The reaction volume is now filled up with RNAse-free water to a total volume
of 15µl, if done so, the samples are incubated for 2min at 45°C and put on ice. Now,
the Reverse-transcription master mix is to be produced. To the previous sample with
a  total  volume  of  15µl  is  now  added  a  5µl  mix  consisting  of  1µl  of  Reverse
Transcription  Enzyme  and  4µl  of  Reverse  transcription  mix.  The  sample  is  now
incubated for  3min at  25°C and again  for  10min at  45°C,  the sample eventually
contains the cDNA. To inactivate the Reverse Transcriptase Enzyme, the sample is
again incubated, this timer for 5min at 85°C. After diluting the sample 1:10, it can be
frozen away at -30°C to -15°C before further use.
37
4.8 Polymerase chain reaction
To understand what physiological and biochemical changes undergo in a cell during
the alteration of their surrounding environment, one key technique in order to check
on the transcription of various genes is the polymerase chain reaction (PCR)(see
figure 6).  During PCR, DNA double strands are broken by high temperature into
single  strands  and  multiplied  by  DNA polymerases,  theoretically  multiplying  DNA
exponentially. In contrast to conventional PCR, during the real-time quantitative PCR
(qPCR), produced DNA is measured at every cycle, allowing it to draw conclusions
on  the  beginning  DNA  concentration  and  thereby  directly  on  the  mRNA
concentration. As the beginning mRNA concentration of a certain gene as such is not
utilizable,  it  has  to  be  compared  with  the  mRNA production  of  genes for  crucial
proteins which are necessitated in the cell at all times (housekeeping genes). As a
control,  the  RNA for  GAPDH  is  outstanding,  as  Glyceraldehyde  3-phopshatase
dehydrogenase is a basic protein for every cell because it is produced at a constant
level over time. To measure the amount of product each cycle, the fluorescent dye
SYBR green, which intercalates double-stranded DNA, was utilized. As SYBR green
only has fluorescent  properties  being  activated by blue  light  when  it  intercalates
double-stranded DNA,  the signal  of  emitted light  rises by the increase of  dsDNA
during subsequent cycles. Figure 6 shows the principle of PCR. Each cycle begins
with the so called denaturation phase, in which dsDNA is melted to ssDNA (in this
case we worked with cDNA which was transcribed from mRNA) at around 95°C.
Thanks to the used taq polymerase, working with such high temperatures is possible,
as  it  won't  denature  at  95°C.  During  the  next  phase,  the  annealing,  the  primers
hybridize. The working temperature is oriented on the melting temperature of the
primers.  The  cycle  ends with  the  extension  phase,  in  which  the  taq  polymerase
extends the DNA strand. If the amplicon is short enough, often the extension phase is
combined with the annealing phase at a working temperature of circa 60°C [185]. In
this  study,  only  cDNA-samples  made  from  corresponding  mRNA  have  been
processed. The cDNA-sample is diluted 1/10 (27µl distilled and sterile water + 3µl
cDNA).  The forward-  and reverse primers are diluted 1/10.  A master  mix is  now
produced for  every gene which  has to  be examined:  for  10µl  volume/wells,  50µl
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SYBR green fast (Life technologies) + 22µl distilled and sterile water + 4µl forward-
primer + 4µl reverse-primer. Every master mix is transferred in triplets on a PCR-
plate  (8µl  master  mix/well).  Finally  the  cDNA-sample  can  be  given  to  the  wells
containing  their  related  master  mix  (2µl/well;  10µl  total  volume in  each well).  To
ensure that there are no air bubbles in the sample, the plate is centrifuged briefly,
consequently it can be processed by the thermo cycler (7500 Fast Real-Time PCR
System by ThermoFisher Scientific). The thermo cycler first runs one cycle for 2min
at 95°C, then 40 cycles 5s each at 95°C. If done so it runs another 40 cycles, this
time 30 seconds each at 60°C. Thermo cycler finishes its program by performing 5s
cycles reducing the temperature for every cycle by 0,5°C from 95°C to 65°C.
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Figure 6: The principle of PCR. Polymerase chain reaction is a crucial technique to detect e.g. the
cell's production of various gene products. By multiplying existing DNA or cDNA strands, the activity of
certain genes can be estimated. As control, so called housekeeping genes are also part of any qPCR.
These genes are obligatory to maintain the functionality of  a cell  and are usually expressed at  a
constantly high level. In our examination, the gene for GAPDH served as a housekeeping gene. The
educts needed for PCR are DNA or cDNA, primers,  nucleotides and taq-polymerases.  During the
process  of  PCR,  DNA is  multiplied  exponentially  according  to  the  scheme.  Before  initializing the
reaction, the dsDNA mother strand has to be denatured, thereby creating ssDNA. This is usually done
by thermic energy. The commonly used temperature lies approximately at 95°C. The primers now can
bind at 40°C – 70°C to their specific locus in the ssDNA, so called annealing, enabling taq-polymerase
to lengthen the daughter strand in 5'-3' direction at 70°C – 72°C. When taq-polymerase reaches the 5'
end of the mother strand, DNA synthesis comes to a halt, dsDNA has been generated. With dsDNA
being present, the cycle can start over.
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4.9 Protein isolation
After harvesting and counting of the cells, samples are centrifuged (300g, 4min, 4°C)
and resuspended in 300µl of lysis solution (1ml RIPA-buffer + 50µl protease inhibitor,
provided by ThermoFisher Scientific). The sample is vortexed shortly and put 10min
on ice before it's again vortexed and put for another 10min on ice. Then the sample is
centrifuged  for  20min  at  14000g  at  4°C  and  afterwards  the  supernatant,  which
contains  the  proteins,  is  collected.  In  order  to  determine  the  amount  and
concentration of protein that has been isolated, we performed a protein concentration
measurement by using a protein assay kit  (Thermo Scientific  Pierce BCA Protein
Assay Kit): To calculate the total working reagent, the number of standards (BSA in
the following concentrations: 2000µg/ml; 1500µg/ml; 1000µg/ml; 750µg/ml; 500µg/ml;
250µg/ml; 125µg/ml, 25µg/ml; 0µg/ml) is added to number of unknown samples, then
multiplied by the number of replicates and again multiplied by the volume of working
reagent per sample (200µl). The working reagent is then prepared by mixing reagent
A (50 parts) with reagent B (1 part). We proceeded with the microplate procedure. To
do so, 25µl of each standard or unknown replicate is transferred into a microplate
well, subsequently we added 200µl of the working reagent and mixed the sample for
30s. Afterwards, the plate is incubated at 37°C for 30min. After cooling down the
plate to room temperature, the spectrometric measurement at 562nm is undertaken.
To calibrate the instrument, the absorbance of a cuvette with water is measured by a
spectrophotometer. The resulting absorbance is subtracted from the absorbance of
all other samples, which are measured now. Afterward a standard curve is generated
by plotting the absorbance of the BSA standard solutions against their concentration.
This standard curve is  then used to  calculate the unknown protein  concentration
[184].
4.10 cDNA-gel
4%  agarose  gel  was  prepared  as  follows:  4g  agarose  (standard  gelling/melting
temperature Agarose by Biozym scientific D31840 Oldendorf) is solved in 100ml 1x
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TAE-buffer. The solution is heated up in a microwave and mixed until  there is no
particulate matter left and the solution is clear. While gently shaking the reagent to
prevent  the  agarose  from  precipitating,  the  liquid  is  cooled  down  to  room
temperature.  Then 10µl  1/10000 cybergreen safe is  added and subsequently the
material is poured into the gel chamber to let it harden. 2µl loading buffer is added to
the cDNA-sample (10µl; total  volume of sample 12µl) and samples can be gently
transferred  to  the  pockets  in  the  now hardened  gel.  For  each  row there  will  be
inserted 5µl marker as control in an extra pocket. A current is applied and the gel is
run until  the samples have traveled a sufficient distance through the gel. If this is
ensured, the gel block can now be viewed by ultra violet light.
4.11 Western Blot
A Western Blot starts with the production of the separation gel, in this case a 7%
separation gel. To do so, one starts with 2,5ml TG-buffer (1,5M Tris base, 4% SDS,
pH 8,8) to which 5,66ml water and 1,75ml acrylamide are given. Subsequently to this
is added 75µl APS and 15µl TEMED. The liquid is poured into a form and given time
to  harden.  Now the  sample  is  prepared  by  putting  together  75µl  of  the  sample
(1,202mg protein/ml) and 2x Laemmlie buffer (reduced). This is incubated for 5min at
95°C to disrupt the superstructure of the proteins. At this point the collection gel of
4% has to be prepared, starting with 1,25ml 4x SG-buffer (0,5M Tris base, 4% SDS,
pH 6,8) to which is added 3,21ml water, 500µl acrylamide, then 37,5µl 10% APS and
7,5µl  TEMED. This  reagent  is  now poured  into  its  form.  Finally  the  sample  and
marker  are put  into  the pockets  of  the gel  which is  placed in  an electrophoresis
chamber that is filled with 10' SDS electrophoresis buffer (1% SDS, 250mM Tris-HCl,
1,92%M Glycin) and a voltage of 100V is applied for 1 to 2h,  dependent on the
distance the sample traveled through the gel. After blotting the membrane, it can be
developed. First of all the membrane is blocked for 1h at room temperature in skim
milk in TBST. After blocking the membrane, the antibody is applied to the membrane,
which is then incubated over night at 4°C. After incubation, the sample is washed 3
times for 5min in TBST. Now the secondary antibody may be applied, the antibody
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has  to  be  incubated  for  1h  at  room  temperature  in  skim  milk.  If  done  so,  the
membrane is washed again 2 times for 10min with TBST, and then washed again
once  with  TBS for  10min.  1Ml  of  luminol  and  1ml  of  enhancer  is  added  to  the
membrane, again an incubation step of 1 minute follows. The sample can now be
measured.
4.12 Mice
All performed experiments in which animals were used have been approved by the
Landesamt für Verbraucherschutz, Saarbrücken, Germany. Upon arrival, the animals
were at least allowed 72h of rest to recover from the transport as they were held in a
pathogen free  environment  (mouse cabinet  purchased from Bioscape).  The mice
used in this work were female C57BL/6 mice, a commonly used wild type, purchased
from Charles River (Sulzfeld, Germany), aged around 7 to 8 weeks at the time of the
experiments. If not otherwise mentioned, the mice had access to food and water at
will. Food and water have been monitored daily and cages were exchanged at least
once a  week.  Mice in  the  starvation  group were  denied food for  48h (starvation
phase)  but  had  free  access  to  water.  In  the  regression  phase  group:  After  48h
starvation period food was given back to the animals for another 72h. The mice have
been processed according to 4.2.2.1.
4.13 Calculation, analysis and software
Data collected with flow cytometry has been analyzed with FlowJo (10.0.8) by the
company FlowJo,  LCC.  Statistical  analysis  has  been  performed with  the  help  of
PRISM 5.03, provided by the company GraphPad Software Inc. La Jolla, CA , USA
and Microsoft Excel by Microsoft Corporation, One Microsoft Way, Redmond, USA.




5.1 Analysis of the lymph node structure
5.1.1 Establishment of a staining scheme
To differentiate  the various hematopoietic cell  populations within  the lymph node,
such as macrophages, dendritic cells, T-cells, B-cells and stromal cells like fat cells,
progenitor cells,  blood endothelial  cells, lymphoid endothelial  cells and fibroblastic
reticular cells, a complex gating strategy is crucial. The first step in gating stained
digested lymph node tissue consists of gating out cell debris, as debris can give a
false positive signal in fluorochrome-related channels. Another similar negative effect
on  the  purity  of  the  result  is  caused  by  dead  cells  that  can  bind  to  dye-linked
antibodies  and can appear  unspecifically in  any channel.  As  figure  7  shows,  the
biggest contingent of cells in lymph node are undoubtedly leukocytes, in this case
more than 99% of the lymph node's cell population (erythrocytes already excluded),
which can be differentiated from stromal cells mainly by their carried surface marker
CD45. This surface protein belongs to the family of protein tyrosine phosphatases
and has a crucial role in terms of cell growth and development [148]. The cells which
are not in the CD45 positive gate are known as stromal cells. They only make a small
amount of  the total  cell  composition of the lymph node. Nevertheless the stromal
compartment  consists  of  multiple  populations as mentioned above.  To distinguish
them, fluorescence-labeled antibodies against  CD31 and gp38 are necessary.  By
using both of these antibodies, one can clearly see a separation between the four
stromal populations (as shown in figure 7): Blood endothelial  cells are only CD31
positive  and  fibroblastic  reticular  cells  are  only  gp38  positive,  while  lymphatic
endothelial  cells  carry both of  these markers on their  surface.  When intended to
prove whether FRCs posses leptin receptor in their cell membrane, a leptin receptor
staining is added and checked in a last gate on FRCs.
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Figure 7: Exemplary gating of stromal cell populations: An exemplary gating for most experiments
is displayed in this figure, the subfigures will be explained in the following part. a) As small cell-like
bodies like microparticles, extracellulary vesicles, microsomes, apoptotic bodies and cell debris are not
focus of the investigation in this work, they are ruled out by using forward and sideward scatter given
that  these  cell-like  bodies are  as  a  rule  smaller  than regular  cells.  b)  Doublets,  triplets  etc.  can,
dependent on the target of research, falsify the result. In the aspect of differentiation within the stromal
cell  department  however,  it  is  not  always  necessary  to  exclude  cell  agglomerates  since  these
populations can be clearly distinguished by the help of their markers. To see whether a signal comes
from a cell cluster or from a single cell, one compares forward scatter width and forward scatter height
and all  single cells  should  be within  a certain range around a linear  line which is  determined by
extrapolation of the beginning slope of the signal. The more volume a single cell gains, the more rises
its signal from forward scatter width and forward scatter height, a cell doublet of the same volume is
more likely to just have an increased signal in the forward scatter width. Because of that, every event
not in this range is likely to be a cell cluster and therefore excluded from further gating. c) Dead cells
are excluded by gating out DAPI positive signals (provided by Miltenyi Biotec, Bergisch Gladbach),
hence dead cells can't transport this molecule out of their cell core in the extracellular space and so
they appear positive in the corresponding channel [182]. PI (provided by Miltenyi Biotec, Bergisch
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Gladbach) on the other hand is not able to pass the membrane of living cells, so dead cells stained
with PI  show a positive  signal  in the corresponding channel [183].  d) Ter 119 is used to rule out
erythrocytes, while Ter 119 positive cells are classified as erythrocytes, all Ter 119 negative cells are
not and therefore further gated [108, 70]. e) Leukocytes are characterized by the surface marker CD45
[18]. If leukocytes were target of the examination, all CD 45 positive cells have been gated and further
characterized with specific antibody combinations. Stromal cells however do not carry CD45 on their
surface and are therefore contained in the CD 45 negative gate.  f) Whereas both endothelial  cell
types, the lymphatic and blood endothelial cells carry CD31, only lymphatic endothelial cells carry
gp38. On the other side fibroblastic reticular cells are also in possession of gp38 but one does not find
CD31 in their membrane, allowing to distinctively distinguish these three populations [61].
5.1.1.1 Outgating of cell debris
As  small  cell-like  bodies  like  microparticles,  extracellular  vesicles,  microsomes,
apoptotic bodies and cell debris are not focus of the investigation in this part of the
experiment,  they are ruled out  by using forward and sideward scatter,  given that
these cell-like bodies are smaller than regular cells, see figure 7a). 
5.1.1.2 Doublet exclusion
Similar to cell  debris, doublets,  triplets etc. can falsify the result.  In the aspect of
differentiation within the stromal cell department however, it is not always necessary
to exclude cell agglomerates since these populations can be clearly distinguished by
the help of their markers. To see whether a signal comes from a cell cluster or from a
single cell, one compares forward scatter area and forward scatter height. All single
cells should be within a certain range around a linear line which is determined by
extrapolation of the beginning slope of the signal.  The more volume a single cell
gains, the more rises its signal from forward scatter area and forward scatter height,
a cell  doublet of the same volume is more likely to just have either an increased
signal in the forward scatter area, or in the forward scatter height, dependent on the
steric orientation of the cell cluster. Because of that every event which has either a
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strong signal on either of both detectors is likely to be a cell cluster and therefore
excluded from further gating (see figure 8).
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Figure  8:  Differentiation  between  single  cells  and  cell  clusters:  This  illustration  shows  how
forward scatter  height  and forward  scatter  area react  to  different  cell  constellations and how the
resulting data  can  be interpreted.  Whereas the  image shows on the  left  side  a  big  cell  with  the
dimensions width=a and height=a, which will move through the light beam in the following subimages,
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on the right side it shows two smaller adherent cells, a so called doublet, with the dimensions width=a
and height=a/2, is moving through the light beam. Next to the cells, the related signal of the forward
scatter height on the y-axis and the signal of the forward scatter area on the x-axis is shown. a) The
single cell moves towards the light beam, as it does not cross the laser beam, no signal is triggered. b)
The cell doublet moves towards the laser beam, as it does not cross the laser beam, no signal is
triggered. c) The single cell enters the laser beam, its bigger diameter results in a higher signal of the
forward scatter height. d) the doublet enters the laser beam, since its diameter is smaller than the
bigger cell's, the signal of the forward scatter height is also smaller. e) The single cell moves through
the laser  beam, as its  maximum diameter  is  reached,  the forward scatter  height  signal  does not
increase, whereas the forward scatter area signal still ascends. f) The doublet moves through the laser
beam, as its  maximum diameter  is  reached,  the forward scatter  height  signal  does not  increase,
whereas the forward scatter area signal still ascends. g) The single cell leaves the laser beam, the
forward scatter height and area signals decline and reach zero. h) The doublet leaves the laser beam,
the forward scatter height and area signals decline and reach zero. This illustration shows that the
relation of forward scatter height and area when measuring single cells is always close to 1, while the
relation of forward scatter height and area drops the more cells are chained together. This explains the
structure of the gate to rule out cell agglomerations, since it is by approximation the bisectrix of the y-
and x-axis.
5.1.1.3 Dead cell exclusion
As a dead cell dye 4'6-Diamidin-2-phenylindol (DAPI) and propidium iodide (PI) have
been  used.  The  use  of  either  of  these  dyes  was  dependent  on  additional
fluorochromes in the staining mix. If these were detected in the V1-channel of the
flow cytometer, PI instead of DAPI has been used since DAPI is also detected in the
V1-channel, whereas PI is detected in the channel B3 (480 nm laser, 655-730 filter).
Along with their  different  detection channel,  the staining mechanism of these two
dead cell dyes is different. DAPI passes the cell and core membrane of both, dead as
well as living cells and binds to the AT region of dsDNA. The living cell entry is less
efficient  and appears lower than the dead cells,  additionally,  living cells  transport
DAPI  to  the  extracellular  space.  DAPI  positive  cells  appear  positive  in  the
corresponding channel when excited by light of a wavelength of 405 nm [182]. PI on
the other hand is not able to pass the membrane of living cells so that it is commonly
used to for dead cell stains. When this compound is in solution it has its excitation
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peak at 493 nm and its emission peak at 636 nm, once bound, the fluorescence
enhances by 20 to 30 fold and the excitation and emission spectrum changes to 535
nm for excitation and 617 nm for emission [183]. As shown in figure 7, dead cells are
excluded by gating on the DAPI and PI negative section.
5.1.1.4 Exclusion of erythrocytes
During the  course of  preparation,  erythrocytes  are enriched as by-product  of  the
digest. Erythrocytes carry neither CD45 nor CD31 or gp38 and therefore appear in
the double negative gate of the stromal cell compartment. Ter119 was used to rule
out erythrocytes. This surface marker is present on the red blood cell development
line from proerythroblasts up to adult erythrocytes [186]. Ter 119 antibody's conjugate
PE-Cy 7 is detectable by showing a signal in the channel B4 (laser 488 nm; filter 750
nm LP) and therefore can be outgated unambiguously.
5.1.1.5 Leukocyte gating
Leukocytes are with approximately more than 99% of the total lymph node's cells the
biggest  population  of  this  secondary  lymphoid  organ.  Therefore  it  is  of  most
importance to  gate on leukocytes precisely because they can easily derange the
results of the analysis. The leukocytic surface marker CD45 belongs to the protein
tyrosine  phosphatase  family,  which  is  known  to  modulate  cell  development  like
mitosis, growth, differentiation and oncogenic transformation. CD45 also regulates T-
and  B-cell  antigen  receptor  signaling.  CD45  has  an  extracellular  domain,  one
transmembrane chain and an intracellular catalytic domain which is composed of two
tandem chains  [34,  148].  If  leukocytes  were  target  of  the  examination,  all  CD45
positive  cells  have  been  gated  and  further  characterized  with  specific  antibody
combinations.
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5.1.1.6 Differentiation of the stromal cell compartment
In  order  to  identify stromal subpopulations,  in this  study,  two main markers were
utilized: CD31 and gp38 also known as podoplanin. EndoCAM, PECAM1 or CD31 is,
as  its  first  abbreviation  suggests,  a  protein  which  is  strongly  represented  in
endothelial cell types such as blood endothelial cells and lymphatic endothelial cells.
Furthermore it is also translated within the cells of the hematopoetic line, such as
certain  macrophage  populations.  CD31  is  related  to  immunoglobulins  and  plays
probably a role in leukocyte migration, intercellular connections between endothelial
cells,  activation of integrins and angiogenesis [33].  The other important marker is
podoplanin, which is a type-1 integral membrane glycoprotein that can help to further
discriminate  within  the  stromal  cell  compartment  [35].  While  both  endothelial  cell
types,  the  lymphatic  and  blood  endothelial  cells,  carry  CD31,  only  lymphatic
endothelial cells carry gp38. On the other hand, fibroblastic reticular cells are also in
possession  of  gp38  but  do  not  express  CD31  in  their  membrane,  allowing
distinguishing these three populations as seen in figure 7. CD31 with its FITC dye
appears  positive  in  the  channel  B1  (laser  488  nm;  filter  525/50  nm)  whereas
podoplanin with its APC-Cy 7 conjugate is detectable in the channel R2 (laser 635
nm; filter 750 nm LP).
5.1.2 Lymph node structure in mice
The main target of this research was to rule out how the structure of lymph nodes in
respect  of  their  cellular  composition  is  affected  by  periods  of  starvation  and
recovering from it. This is relevant not just in sight on today's popular diets but also in
respect of unregular food uptake or famine and related immunodefiency as well as
cancer cachexia. In this study, the focus lays on the contribution of distinct lymph
node  cellular  populations. Special  emphasis  was  put  on  dendritic  cells  and
fibroblastic reticular cells, as these have been shown to interact in order to adapt
lymph  node  size  and  structure  to  external  stimuli  [11],  thus  contributing  to  an
environment in which immune response can be initiated and controlled properly. To
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investigate this, mice were separated into three groups: One group with ad libitum
acces to food and water, one group with ad libitum acces to water but not to food for
48h (so called starvation group).  And a third  group,  which after  treatment like in
starvation group was granted access to food and water for 72h (so called regression
group). The following section describes the results determined by these experiments.
5.1.2.1 Distribution of FRCs
FRCs, or fibroblastic reticular cells are a stromal subset which is characterized as
CD31 negative  and  gp38  positive.  They build  up  the  lymph  node's  scaffold  and
reticular fiber network, in which soluble molecules such as cytokines and antigens
are transported.  Furthermore they are able to  modulate T-cells  and are therefore
important  actors  in  the  immune  system.  The  following  section  deals  with  the
dispersion of fibroblastic reticular cells in subcutaneous lymph nodes during steady-
state,  starvation  and  regression  from  starvation.  Analyzing  the  data  of  our
experiment, we estimate around 2163,36 fibroblastic reticular cells to be averagely
present in one subcutaneous lymph node of a C57Bl/C57Bl/6 mouse. The values
however range from 558 FRCs per lymph node up to 4382 FRCs per lymph node
(see figure 9a). If it comes to starvation, the average amount of fibroblastic reticular
cells  counts 1830,83 per  subcutaneous lymph node,  ranging from 267 FRCs per
lymph  node  up  to  2838  FRCs  per  lymph  node.  This  difference  however  is  not
significant  (p=0,5881;  unpaired  t-test;  n(control)=11;  n(starvation)=6;  figure  9a).
Surprisingly,  in  the  regression  group,  a  heavy  drop  in  fibroblastic  reticular  cell
numbers happens, which we detected 72h after the starvation phase ended (see
figure 9b). The average count of fibroblastic reticular cells after 48h of starvation and
the subsequent 72h regression phase is 719,333 per subcutaneous lymph node. The
individual values ranged from 252 cells per lymph node up to 1492 cells per lymph
node. These values monitor a significant decrease in cell numbers compared to the
control group (p=0,0164; unpaired t-test; n(control)=11; n(regression)=6; figure 9b).
Not just compared to the control group, but also compared to the starvation group
this change in numbers was significant (see figure 9c), as the number of FRCs in the
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regression group was obviously lower than those in the starvation group (p=0,0459;
unpaired  t-test;  n(starvation)=6;  n(regression)=6;  figure  9c).  To  check  on  the
composition of the stromal subsets, also the distribution of cellular frequency and not
just the absolute numbers of these cells were examined. Figure 16 illustrates the
cellular frequencies within the stromal compartment. Double negative cells have not
been included in the percentages due to technical reasons. In the control group, the
biggest portion with an average percentage of 43,398% of all stromal cells is build up
by FRCs (n=11), followed by LECs (n=11) with 32,754%. BECs represent an average
percentage  of  23,848%  (n=11).  These  differences  however  are  not  significant
(p>0,05). A different, yet not significant difference is presented by the dispersal of
FRCs in the starvation group (p>0,05). Averagely 36.509% of the stromal cells are
made up by fibroblastic reticular cells (n=6), whereas the biggest population in the
starvation group, exhibited around 39.720%, is formed by lymphatic endothelial cells
(n=6).  Again,  the  smallest  population  are  the  blood endothelial  cells,  contributing
23,771% to the stromal species (n=6). The last group, the regression group, shows
again a slightly different picture. There average values of the three cell types lie more
closely together than in the other groups. The largest population is, like in the control
group, represented by fibroblastic reticular cells, with an average value of 38,275%.
This time, the smallest population are the LECs, with an average portion of 29,794%.
Surprisingly, the centre span is represented by blood endothelial cells, as average
31,931% of the stromal subsets. As it was the case in the control group and in the
starvation group, these differences are not significant as well (p>0,05; 2way ANOVA;
n=6 mice/group).  There are no other  significant  alterations detectable among the
populations.  A synopsis  of  the absolute numbers and relations between all  three
models is given in figure 10, where also representative gates of the cells are shown.
Figure 15 a)-e) illustrates the position of FRCs within the stromal cell compartment.
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Figure 9: Distribution of FRCs: In this figure the distribution of FRCs per lymph node is illustrated. 
The medium bar represents the mean of the given values whereas the lower and upper bar include the
95% confidence interval. a) The comparison of the amount of FRCs per lymph node in healthy control 
mice (n=11; mean=2163,36 cells/ lymph node) and mice in the state of starvation (n=6; mean=1830,83
FRCs/lymph node) does neither show a significant difference on the 5% significance level (p=0,5881) 
nor a tendency towards any direction. The highest values in cell count though belong to the control 
model. b) However if the FRCs of the control group (n=11; mean=2163,36 FRCs/ lymph node) are 
compared to the group of mice recovering from starvation (n=6; mean=719.333 FRCs/ lymph node), a 
significant change between two groups is attestable (p=0,0164) in respect of reduced numbers of 
FRCs in the regression model. c) Also among the starvation group (n=6; mean=1830,83 FRCs/ lymph 
node) and the regression group (n=6; mean=719,333 FRCs/lymph node) there is a significant change 




Figure 10: Synopsis of FRC distribution: Figure 10 incorporates the synopsis of figure 9 with an
included flow cytometry dot plot example. a) Again plotted on the y-axis is the count of FRCs per
lymph node and plotted on the x-axis is the corresponding mouse model. The medium bar shows the
mean of the values of each group (mean of control group =2163,36 FRCs per lymph node (n=11);
mean of the group of mice in the state of starvation =1830,83 FRCs per lymph node (n=6); mean of
the regression group =719,33 FRCs per lymph node (n=6). b) Shows the composition of the stromal
cell department after a digest for the production of a single sell suspension with 23,7% BECs, 19,5%
LECs, 36% FRCs and 20,7% double negative cells. As in c) and d) in b) on the y-axis is plotted the
channel for FITC labeled CD 31 and on the x-axis is plotted the channel for APC labeled gp38. Similar
to b) figure 10c) shows the fragmentation of the stromal party in starving mice with 15,3% BECs,
33,6% LECs, 33,4% FRCs and 17,7% double negative cells. d) Introduces the division of the stromal
compartment within recovering mice with 14% BECs, 17% LECs, 18,5% FRCs and 50,6% double
negative cells.
5.1.2.2 Distribution of lymphatic endothelial cells
Lymphatic endothelial cells, or LECs, are a stromal subset which is characterized by
the expression of both, CD31 and gp38, and therefore it is easy to discriminate them
from fibroblastic reticular cells and blood endothelial cells. Although they belong to
the  stromal  cell  compartment,  they  fulfill  an  entirely  different  tasks  than  the
fibroblastic reticular cells as they are more closely related to blood endothelial cells
[195]. LECs build the afferent and efferent lymphatic vessels as their name suggests.
The following paragraph deals with the apportionment of these cells in subcutaneous
lymph nodes in steady-state situations and in the phase of starvation as well as in the
post starvation regression phase. An average of 1633,91 lymphatic endothelial cells
populate a subcutaneous lymph node of  a  C57Bl/6 mouse.  But  also  here,  a  big
variation could be determined, as the values vary from 506 cells per lymph node to
3526 cells per lymph node (see figure 11a)). These values have been determined
based on 11 mice/group. The absolute numbers of lymphatic endothelial cells in mice
that suffered from 48h starvation showed an analog picture. Averagely 1951 LECs
inhabit a single lymph node of starving mice. The range however spans a spectrum
from 503 individuals per lymph node to 3974 lymphatic endothelial cells per lymph
node.  The  numbers  are  alike  to  those  of  the  control  group,  hence  there  is  no
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significant difference between the two groups (p=0,5835; student t-test)(see figure
11a). Similarly, fibroblastic reticular cells, isolated from mice of the regression group,
which suffered 48h from starvation and then had a time span of 72h to recover from
the famine, show a massive drop in not just the mean of the cell number, but also the
upper  range  value  drastically  dropped  (see  figure  11b).  The  average  amount  of
lymphatic  endothelial  cells  was  an  astonishing  601,5  cells  in  one  subcutaneous
lymph node, meaning approximately just a third of the mean amount of LECs in the
control (mean=1633,91 LECs/ lymph node) and starvation group (mean=1951 LECs/
lymph node). The lowest value counts a total of just 171 lymphatic endothelial cells
per lymph node and the highest value is measured with 1317 cells per lymph node.
This value is far from the mean of the control group or the mean of the starvation
group. Hence it is not surprising that a significant difference can be detected if one
compares  the  values of  the  regression  group  to  the  values  of  the  control  group
(p=0,0314; student t-test)(see figure 11b)) or of the values of the starvation group
(p=0,0416; student t-test)(see figure 11c)). To see what effects the drop in numbers
has on the non-hematopoietic compartment as a whole, also the relative amount of
the cells within the stromal cell compartment was determined (see figure 16). While in
two of the three groups, namely in the control and the regression group, lymphatic
endothelial cells are the second biggest stromal subset, in the starvation group, they
are the biggest group in respect of sheer numbers and in frequency distribution. In
the control and in regression group, they are outnumbered by the fibroblastic reticular
cells.  While  their  part  in  the  stromal  compartment  is  averagely 32,754%,  that  of
fibroblastic reticular cells' counts 43,398%. Blood endothelial cells have an average
percentage of 23,848% within all  stromal cells, however these differences are not
significant (p>0,05; 2way ANOVA). As mentioned above, the LECs' compartment is
the biggest compared to the other stromal cell populations in the starvation group,
counting  39,72%.  The  LECs  outmatch  the  fibroblastic  reticular  cells  hereby  by
approximately 3,2%, as the FRCs' average portion is 36,513%. The smallest group is
constituted by blood endothelial cells with an average percentage of 23,771%. Also
here, the differences between the groups are not significant (p>0,05; 2way ANOVA).
The regression group shows again the usual distribution of fibroblastic reticular cells
being the biggest subset with 38,275%, followed this time by blood endothelial cells
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making up the stromal compartment with 31,931%. The smallest group of stromal
cells in the regression group is that of the lymphatic endothelial cells with an average
value of 29,794%. The values however do not differ enough to certificate a significant
change (p>0,05; 2way ANOVA).  To take together  this  data,  figure  12 presents  a
synopsis  in  which  the  total  values  of  all  three  groups  are  juxtaposed.  Also  an
exemplary gating how the stromal compartment in every model would look like is




Figure 11: Distribution of LECs: Figure 11 portrays the comparison of the distribution of LECs within
all three groups of mice. Whereas the number of LECs per lymph node is plotted on the y-axis, the
mouse model is shown on the x-axis. The lower and upper bar include the 95% confidence interval,
the  central  bar  marks  the  mean value.  a)  Presents  the  amount  of  LECs  in  control  mice  (n=11;
mean=1633,91 LECs/ lymph node) and starving mice (n=6; mean=1951 LECs/ lymph node), neither a
significant change nor a tendency towards any direction can be proven here (p=0,5835). b) However
highlights a significant loss of LECs populating the lymph node of the regression group (n=6; mean=
601,5 LECs/ lymph node) compared to the control group (n=11; mean=1636,82 LECs/ lymph node)
(p=0,0314). Alike b), c) shows significantly less LECs again in the regression group by contrast with
the starvation group (p=0,0416).
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Figure 12: Synopsis of LEC distribution: This data represents a clear view of the preceding figure
and an exemplary gate showing the stromal compartment. a) Again the ordinate shows the number of
LECs per lymph node and the points on the abscissa stand for the used mouse models. The loss of
LECs in the regression model compared to the other models becomes obvious looking at this graph
(mean value of control group =1633,91 LECs per lymph node; mean of starvation group =1951 LECs
per lymph node; mean of regression group =601,5 LECs per lymph node). Analog to figure 10b), c)
and d) have plotted on the y-axis the channel for FITC labeled CD31 and on the x-axis the channel for
APC labeled gp38. Figure 12b) shows the layout of the stromal cell compartment in healthy control
mice with 13,3% BECs, 33,9% LECs, 25,9% FRCs and 26,8% double negative cells. c) shows the
stromal cell composition of starving mice consisting of 15,3% BECs, 33,6% LECs, 33.4% FRCs and
17,7% double negative cells. d) gives information about stromal cell relations in the regression group,
namely 14% BECs, 17% LECs, 18,5% FRCs and 50,6% double negative cells.
5.1.2.3 Distribution of blood endothelial cells
Blood endothelial cells, or BECs, are a stromal cell subset which is characterized by
the absence of gp38 and the expression of CD31, thus they can be discriminated
from  FRCs,  LECs  and  double-negative  cells  easily.  They  are  closely  related  to
lymphatic  endothelial  cells  [195]  and  adopt  alike  tasks.  They  build  up  the  high
endothelial  venules,  which  are  crucial  for  cell  migration,  especially  T-  and  B-cell
homing.  The  paragraph  below will  elucidate  their  position  within  the  stromal  cell
compartment  during  steady  state,  starvation  and  regression.  The  control  group
consisted  of  11  C57Bl/6  mice  which  had  free  access  to  food  and  water.  The
starvation  group,  consisting  of  6  mice  has  been sacrificed after  a  48h  period  of
starvation, in which they still had access to water ad libitum. The last group had 72h
time to recover from a 48h starvation phase. In steady-state, an average number of
1122,64  blood  endothelial  cells  has  been  determined  to  inhabit  a  subcutaneous
lymph node of a C57Bl/6 mouse, the range however includes values from 405 cells
per lymph node to 2227 cells per lymph node (see figure 13a)). They are therefore
the smallest stromal cell subset in respect of sheer numbers (see figure 15c)) (due to
technical reasons double negative cells have not been included in this consideration).
Alike all other stromal populations, their numbers in the starvation model do not differ
much from the ones of the control  group, for the mean absolute cell  number per
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lymph node in the starvation model is 908,5. A p value of 0,4071 (student t-test)
suggests that there is no significant change in respect of the absolute numbers of
blood  endothelial  cells  during  starvation  (see  figure  13b)).  Different  to  the  other
models, in the regression group again, the number of blood endothelial cells drops
critically, resulting in a mean cell number of 517,833 BECs per lymph node, making a
significant difference to the control group (p=0,0251; student t-test)(see figure 13b))
and to  the starvation group (p=0,0491;  student  t-test)(see figure 13c)).  Figure 16
highlights the relative amount of blood endothelial cells in the stromal compartment of
the lymph node. We see that, in the control group and in the starvation group, it is the
smallest population, as FRCs in the control group represent 43,398% of the lymph
node's stromal cells.  The population of FRCs is followed by lymphatic endothelial
cells whose part of the stromal division is averagely 32,754% in healthy mice. As
stated above, in this model the blood endothelial cells are the smallest population as
they build  up 23,848% of  the  lymph node's  stroma.  Also  in  starving mice,  blood
endothelial  cells  are  the  smallest  of  the  three  stromal  subsets,  as  lymphatic
endothelial cells inhabit the lymph node by making 39,72% of the stroma. This time,
FRCs are only in the centre span with averagely 36,509%. The remaining 23,771%
go to blood endothelial cells. In the last model, the regression model, proportions are
different, compared with the control group, fibroblastic reticular cells represent the
biggest  population  with  38,275%,  followed  this  time  not  by  lymphatic  endothelial
cells,  which  have  this  time  only  an  average  portion  of  29,794%,  but  by  blood
endothelial cells, making out 31,931% of the stromal division. 6 mice belonged to the
regression group. Figure 14a) juxtaposes the absolute cell numbers of each model
for blood endothelial  cells to allow direct visual  comparison, with the cell  number
written on the y-axis and the related model on the x-axis. Beyond, representative
exemplary gates for every model are given, showing how the stromal subset would
presumably  look  like.  A big  summary  is  given  in  figure  15a)-e)  as  it  shows  the
position and distribution of blood endothelial cells within the lymph node. While a)
and b) incorporate the data of all models and all cell types belonging to the stromal
compartment  that  have  been  examined,  c)-e)  give  an  overview  about  the  cell
distribution in distinct models. 
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Figure 13: Distribution of BECs: As we look on blood endothelial cells, figure 13 gives the facts
about the amount of  those cells per lymph nodes (plotted on the ordinate) regarding the nutrition
status (plotted on the abscissa). The bars show the mean and the 95% confidence interval. a) Alike
FRCs and LECs there's no significant difference amongst control and starvation group (p=0,4071;
student t-test). However b) shows a significantly decreased number of BECs in the lymph nodes of
recovering mice, mean(control) =1122,64 BECs per lymph node compared, to mice who didn't hunger,
mean(regression)  =517,833  BECs  per  lymph  node  (p=0,0251;  student  t-test).  c)  Indicates  that
recovering mice also have less BECs than starving mice, mean(stravation) =908,5 BECs per lymph
node (p=0,0491; student t-test).
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Figure 14:  Synopsis of  BEC distribution: This  figure merges figure 13 and has the same axis
labeling concerning a) and again, the graph's bars show mean value and include the 95% confidence
interval.  The  mean  values  show the  decrease  of  BECs  from the  control  group  (n=11)  over  the
starvation group (n=6) down to the regression group (n=6) whereas the difference amongst control
and starvation group is not significant, but it is among control and regression group and also between
starvation and regression group (mean of control group =1122,64 BECs per lymph node; mean of
starvation group =908,5 BECs per lymph node; mean of regression group =517,83 BECs per lymph
node). The dot plots in b) c) and d) point out the apportionment of stromal cells in the different mouse
models.  The  detection  channel  for  FITC  labeled  antibodies  on  the  y-axis  is  plotted  against  the
detection channel for APC labeled antibodies on the x-axis. For b), which represents the control group,
that is 13,3% BECs, 33,9% LECs, 25,9% FRCs and 26,8% double negative cells. The starvation group
example,  present  in  c)  has approximately  the same percentage for  BECs as the healthy control,
namely 11,2%. The percentage of LECs is with 41,1% higher than in the control group. Also increased
is the percentage of FRCs with 37,4% compared to the control group. Only double negative cells with
10,3% have a lower percentage than in healthy control. d) Gives evidence of the stromal compartment




Figure 15: Summary of cellular lymph node composition: The illustration is a summary of the
cellular composition of mice's lymph nodes and accounts for stromal cells as well as leukocytes. The
y-axis is labeled in a), b), c), d) and e) as cells per lymph node and in f) as leukocytes per lymph node.
The x-axis shows in a), c), d) and e) the cell type and in b) and f) the mouse model. In all subfigures
the top of the box represents the mean value and the upper bar represents the upper border for the
95%  confidence  interval.  It  holds  for  the  control  group  n(FRCs;LECs;BECs)=11,  n(DN)=3,
n(leukocytes)=11;  for  the  starvation  group  n(FRCs;LECs;BECs;  leukocytes)=6,  for  the  regression
group n(FRCs;LECs;BECs;  leukocytes)=6 and n(DN)=3.  a)  shows each stromal  cell  population in
comparison  to  the three mouse models  as explained in  the  preceding figures.  b)  shows the cell
composition for each mouse model. c) d) and e) show again the distinct cell numbers for each mouse
model in detail, whereas c) shows the healthy control, d) the starvation group and e) the regression
group. Subfigure f) shows the difference in leukocyte population amongst the mouse models. Here is
to mention that leukocytes in the starvation group are significantly reduced compared to the control
group, and the leukocytes in the regression group are also significantly reduced than those in the
control group (p<0,0001; 1way ANOVA).
Figure 16: Percentual distribution of stromal cells: The illustration above provides an overview on
how the lymph node's stroma is composed. The y-axis shows the percentage of the cell populations.
a) Discriminates each cell population (x-axis) in respect of the mouse model, while b) shows each
model individually and separates it into stromal subsets. However there are no significant changes
detectable in either of the populations (p>0,05). While FRCs have together with LECs the highest
proportion of the stromal compartment, BECs tend to form the smallest population of all stromal cells.
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5.1.2.4 Leukocytes
In this study, leukocytes are defined by CD45 expression, which includes myeloid
cells,  such  as  dendritic  cells,  macrophages,  granulocytes  on  one  hand  and
lymphocytes and innate lymphoid cells on the other. They are an inhomogeneous
group of cells, as some of them belong to the innate immune system, some to the
acquired immune system and some, such as the dendritic cell, compromise both of
them. Dendritic cells, T-cells and B-cells also have been examined separately in the
murine blood. The examination of leukocytes led to astonishing results: Before the
effect of famine shows in the stromal cell's population, leukocytes already show a
massive drop in numbers, indicating a higher sensitivity to starvation. In the phase of
regression, one can see that the numbers of leukocytes are still decreased, but, even
if  not significantly,  they have a tendency to regenerate. Figure 15f)  illustrates the
dynamics of leukocytes during the experiments. As the mice have access ad libitum
to water and food, the leukocytes counted 3,331*10^6 cells per lymph node, ranging
from 2,053*10^6 cells per lymph node to 4,86*106 cells per lymph node (n=11 mice/
group). As during starvation, the stromal cell compartment, fibroblastic reticular cells,
lymphatic endothelial cells or blood endothelial cells, didn't show a significant change
in  numbers.  This  is  different  within  the  leukocyte's  lineage  as  they  drop  very
significantly  in  numbers  (p<0,01;  1way  ANOVA),  only  having  left  an  average  of
1,368*10^6 cells per lymph node, which is approximately a third of the output value of
the leukocytes in the control group. As one checks on the leukocyte population in the
regression model, one can see that the numbers of leukocytes are still decreased if
compared to  the  control  group.  They count  averagely1,745*10^6  cells  per  lymph
node in an individual which has rested and recovered for 72h after starvation. This is
a  high  significant  change  (p<0,0001;  1way  ANOVA).  However,  the  numbers  of
leukocytes in mice that are recovering and the numbers of leukocytes in mice that




Dendritic  cells,  or  DCs,  are  a  subpopulation  of  leukocytes,  which  possesses the
special property to compromise both, the innate and the acquired immune system, as
they modulate immune response of macrophages and lymphocytes. The dendritic
cell is a professional antigen-presenting cell [163]. Dendritic cells possess the ability
to provide survival signals for FRCs [1, 11], which could be the cause of the massive
drop down of FRCs in regression. We can differentiate resident dendritic cells and
immigrated dendritic cells in the lymph node, which both have different properties
concerning their  movement and resting pattern (see 3.1).  In this study we define
dendritic cells via surface molecules. All cells which are CD45 positive and CD11c
positive are considered to be dendritic cells. Within the CD11c positive compartment,
we distinguish two different  leukocyte populations:  CD11c high and a CD11c low
population. CD11c high cells represent classical DCs while the CD11c low cells are a
mixture of macrophages and DCs. Figure 17 shows an exemplary gating of DCs,
which we used in  our  work.  An overview on how the percentual  dispersal  of  the
classical  dendritic  cells  in  the  lymph  node  looks  like  is  given  in  figure  18.  It  is
apparent that there is a big gap in respect of absolute numbers between the two
described subpopulations (CD11c high and low) as there are more CD11c low+ DCs
present in a single lymph node than there are CD11c high+ DCs. Both populations
are differently affected by the impact of starvation and the following phase of food
reuptake.  CD11c  high+  DCs seem to  be  unaffected  by  the  change  in  nutritional
status,  the  mean  of  CD11c  high+  DCs  per  lymph  node  stays  almost  unaltered
(p=0,8706;  student  t-test;  n(control;  starvation)=3),  as  in  steady  state  there  are
averagely 1,452*10^4 of those DCs present per lymph node and in regression this
number changes to 1,586*10^4. CD11c low+ cells (mixture of myeloid-lymphoid cells)
however  are heavily affected by the status of under nutrition, their  number drops
significantly  (p=0,0463;  student  t-test;  n(control;  starvation)=3)  from  a  mean  of
6,002*10^4 cells per lymph node to a mean of 3,236*10^4 cells per lymph node. It
has to be mentioned that too few mice have been used to produce these values, so
that a valid statistic analysis is not possible here, however it may be possible to see a
tendency. Hence the p value is mentioned for the sake of completeness. The results
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of this experiment remain to be confirmed by higher numbers of repetitions. As all
stromal  populations  drop  in  numbers  during  the  regression  phase,  it  has  to  be
examined if cell death is caused by leptin signaling, the loss of dendritic cells or has
an unknown origin. As FRCs closely interact with immune cells, the reduced number
of  CD11clow cells  during  regression  could  be a  trigger  for  stromal  cell  death  or
alteration. DCs regulate the contractility and survival of FRCs by the help of CLEC-
2/Podoplanin interaction. Gp38 or podoplanin controls the contractility of FRCs via
actomyosin. During steady state, when not bound by a ligand, gp38 signalling leads
to  the  contraction  of  the  FRC's  fiber  network.  However,  during  inflammatory
conditions, DCs migrate to the lymph node and provide FRCs with CLEC-2, CLEC-
2/gp38 binding is critical for the DCs' ability to move along the reticular fiber network,
however the ligation of CLEC-2 to gp38 seems to impair the signaling of podoplanin
and  therefore  allows  them  to  expand  their  reticular  fiber  network [1,  11,  26].
Furthermore,  FRC  survival  is  associated  with  the  elasticity  of  their  surrounding
matrix, loss of elasticity will trigger cell death of those stromal cells. In summary, high
levels of detectable podoplanin per single cell are an indicator for cell death triggered
by the absence of DCs [1,  11].  This is why we examined the expression of APC-
labeled gp38 via the mean and median APC fluorescence in FRCs and LECs (see
Figure 19 and 20). Both figures show the averaged values of both, the mean and the
median APC fluorescence of FRCs and LECs. Each value plotted in this graphic is
the mean or median of the APC fluorescence of all single events in a test run. It is
obvious, that median and mean show a distinct difference between each other. The
mean is prone to outlayers while the median is not, making the median value of APC
fluorescence more meaningful  than the mean value. In FRCs, the mean value of
median and mean APC fluorescence is contradictory, while the average median APC
fluorescence drops during  regression,  the average mean APC fluorescence even
rises. Yet the difference between control vs. regression and starvation vs. regression
is only significant in the median APC fluorescence of FRCs, see (figure 20a)).
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Figure 17:  Exemplary gating of DCs: This figure shows an exemplary gating of  DCs.  a)-c)  Are
similar to figure 7. As DCs belong to leukocytes, a gate has been drawn around CD45+ cells in d).
Subfigure e) shows the differentiation between CD11c high and CD11c low positive DCs within CD45+
cells.
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Figure 18: Dendritic cells: An insight on DCs in the mice's lymph nodes during a normal state of
nutrition and regression is given here. In this setting, 3 control mice and 3 regression mice were used.
Figure  18a)  and  b)  give  an overview of  the  following subfigures.  Figure  18a)  separates  the  two
populations,  shown on the x-axis,  while the absolute number of  dendritic  cells  per lymph node is
shown on the y-axis. In figure 18b), on the x-axis are listed both mouse models and again the y-axis
shows the absolute number of DCs in a lymph node. In all subfigures the mean of the given values is
represented by the medium bar, whereas the lower and upper bar include the 95% confidence interval.
Both subfigures, a) and b), show that the count of CD11c low+ DCs is much higher than that of CD11c
high+ DCs in both, healthy mice and mice in the condition of renutrition. Also, the number of CD11c
high+ DCs does not drop during renutrition, in contrast to CD11c low+ DCs, which drop massively in
numbers. To break down this figures, c) and d) go into detail. Figure 18c) provides information about
CD11b high+ dendritic cells. The y-axis shows again the absolute number of the cells, while the x-axis
shows  the  related  mouse  model,  the  mean  values  do  not  differ  much  from  each  other
(mean(control)=14520,3 cells/  lymph node; mean(regression)=15864 cells/ lymph node), so that no
significance is measurable (p=0,8706; student t-test n(control; regression)=3). When looking at d), one
can see a significant change in numbers. There is a loss of CD11c low+ DCs in the lymph node during
the regression phase, their mean number drops from 60020 cells/ lymph node to 32363 cells/ lymph
node (p=0,0463; student t-test; n(control; starvation)=3).
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Figure 19: Summarization of APC fluorescence of FRCs and LECs: The APC fluorescence is
given on the y-axis on all subfigures. In a) the x-axis shows mean or median APC fluorescence for
FRCs or LECs. The same axis  shows in  b) and c)  the experimental  system. The top of  the box
represents the mean value and the upper bar is the upper border of the 95% confidence interval. a)
Gives an idea of how mean and median fluorescence in FRCs and LECs looks in the different mouse
models. Subfigure b) goes more in detail about mean and median APC fluorescence in the mouse
models. Equivalent to b), c) shows the same issue for LECs.
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Figure  20:  Mean  and  median  APC  fluorescence  of  FRCs  and  LECs  in  comparison: This
illustration deals with the mean and median APC fluorescence in detail. The APC fluorescence on the
ordinate is plotted against the mouse model on the x axis in every subfigure. As in the preceding
figure,  top  row shows  the  mean value  while  the  upper  bar  marks  the  upper  border  of  the  95%
confidence interval.  a)  Pinpoints  the median APC fluorescence  in  FRCs.  While  the  control  group
(n=11) does not show a significant difference to the starvation group (n=6), both, the control group and
the  starvation  group  show  a  significant  difference  to  the  regression  group  (n=6)  which  APC
fluorescence is lower (p=0,011; 1way ANOVA). b) There are no significant differences within the mean
APC fluorescence of the three models detectable (p=0,1211; 1way ANOVA). In contrast to FRCs, the
median  APC  fluorescence  of  LECs  does  not  change  significantly  (mean(control)=10769,5;
mean(starvation)=10247,2; mean(regression)=4681,5)(p=0,8927, 1way ANOVA, see subfigure c)). Yet
d)  shows  that  the  mean  APC fluorescence  in  LECs  differs  between  the  models.  The  difference
between the mean APC fluorescence of the control group and regression group is very significant
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(mean(control)=16679,6; mean(regression)=15511,2), the difference between the starvation group and
regression group is very significant (mean(starvation)=15806)(p=0,008; 1way ANOVA).
5.1.3 Steady state and changes in blood
Blood  is  the  main  traffic  route  for  hormones,  cytokines,  chemokines,  antigens,
catabolic and anabolic molecules, antibodies, complement factors and cells. As there
are many cells which migrate between blood and lymph node, the focus in this part of
the study lies on T- and B-cells. It is of interest to see how a change in lymph node
structure  happens  during  starvation,  so  we  questioned  whether  these  cells  are
influenced by the effect of a reduced leptin level on FRCs. FRCs provide important
homing and survival signals for T-cells, such as CCL21, which is a ligand of CCR7.
CCL21 is expressed in a constitutive manner by FRCs. It is not upregulated under
inflammatory conditions. Next  to  cytokines that  maintain T-cell  homing properties,
there are cytokines produced by FRCs which support T-cell survival such as CCL19
[44].  Therefore,  it  is  interesting  to  see in  how far  the  possibly changed cytokine
pattern of FRCs changes the numbers of T- and B-cells in blood. The experimental
setting is exactly like the one in the lymph node examination, as blood was taken
from the animals that have participated in these experiments, just that no blood has
been taken from the regression group due to technical  reasons.  To generate the
blood sample, which was used to check upon lymphocytes, the technique described
in  4.5  has  been  used.  Figure  21  gives  an  exemplary  gating  of  the  lymphocyte
populations for FACS analysis.
5.1.3.1 T-cells
There are several  subtypes of  T-cells which fulfill  manifold tasks and all  of  them
modulate the immune response. Furthermore these tasks can roughly be grouped in
activation of the immune system, or restriction of it, dependent on the type of T-cell.
They  are  characterized  by  the  presence  of  CD3,  which  together  with  the  T-cell
receptor  (TCR)  forms  the  T-cell-receptor-complex  [164].  Commonly  known  T-cell
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types  are  helper  T-cells,  which  are  defined  by transcription  factors  and  secreted
cytokines,  cytotoxic  T-cells  and  a  plethora  of  other  T-cell-like  cells  that  do  show
expression of molecules, associated with innate immune responses as well, such as
NK-T-cells or gamma/delta-T-cells.  In this study however,  we examined all  T-cells
bearing CD3 and did not conduct a further specification. First of all we looked at the
absolute number of T-cells in blood. Figure 22a) illustrates the count of described
cells in 1ml of mouse blood. In healthy mice, the average number of T-cells per ml
blood counts  929,907 cells/ml  blood.  In  the  starvation  group however,  this  value
almost  halves,  being 539,946 cells/ml  blood,  a p value of  0,2279 (student  t-test)
suggests a missing significance, but as n is only three for both models, the number of
used  test  subjects  has  to  be  increased  to  make  a  valid  statement  about  the
significance of this difference, as a tendency is visible.
5.1.3.2 B-cells
Not as various in their subpopulations as T-cells, but genetically at least as variable,
B-cells portray the other significant cell type of lymphocytes. As main actors of the
immune system they provide vital support by producing antibodies when activated
and  differentiated  towards  a  plasma  cell.  They  are  typically  CD45  positive  and
exclusively  express  CD19  and  CD20,  making  it  easy  to  detect  those  cells  with
immune stainings, as from a morphological point of view, they very much look alike
their CD3 positive counterparts. Figure 22 shows the number of B-cells in blood of
mice in the condition of starvation (n=3) and under sufficient nutrition (n=3). As the
number of experiments is too low to confirm a significance between both models,
there is an obvious trend towards a drop in numbers under starvation visible, for the
mean of the control group is 48965 cells/ml blood and for the starvation group 11831
cells/ml blood.
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Figure 21: Exemplary gating of lymphocytes: This figure shows an exemplary gating strategy to
examine Lymphocytes. a)-d) are similar to figure 7. e) shows the differentiation between T-cells and B-
cells. While CD3e, a pan-T-cell-marker is labeled with A488 which appears in the FITC channel, CD19,
a marker for B-cells, appears in the PE channel. Next to CD3e+ CD19- T-cells and CD3- CD19+ B-
cells, there are double negative and double positive cells.
81
Figure 22: T-cells and B-cells in blood: This figure deals with absolute numbers (cells/ml blood) of
T-cells, B-cells, double- positive and double-negative cells. Again the x-axis shows the mouse models,
control (n=3) or starvation (n=3), and the bars represent mean and confidence interval, on the y-axis
the absolute cell number with cells per ml blood is shown. Even if a tendency to a lower cell number in
starvation is visible, these differences are not significant on a 5% significance level. a) T-cell numbers
are given here for both, the control and starvation group (CD3e positive CD19 negative). The mean of
the T-cell  number per ml blood in the control group adds up to 929,907 cells/ml blood, the range
spanning a band from 463,287 cells/ml blood to 1303,2 cells/ml blood, while the mean value for the T-
cells/ml blood in the starvation group measures 539,946 cells/ml blood, ranging from 316,635 cells/ml
blood to  723,261 cells/ml  blood,  however  no significant  difference  can  be found here (p=0,2279;
student t-test). b) The B-cell number (CD19 positive CD3e negative) is illustrated in this subfigure,
showing again the control and the starvation group. The mean cell amount per ml blood in the control
group counts 48965 cells/ml blood, while the values range from 17328,3 cells/ml blood up to 81138,5
cells/ml blood. In the starvation group the mean value, counting 11831 cells/ml blood is lower than in
the control group, and ranges from 6552,68 cells/ml blood to 16648,3 cells/ml blood. However this
difference is not significant (p=0,1173; student t-test). c) The numbers of CD3e and CD19 positive
cells are shown in this subfigure. The control group shows a mean of 34052,2 cells/ml blood, again a
lower mean value is presented by the starvation group, which counts only 6099,39 cells/ml blood, the
difference is not significant (p=0,1193, student t-test). CD3e/CD19 double positive cells are usually not
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existent in living mice, it is supposedly a mere artifact, caused by the process of freezing the mouse
blood before processing it, several working groups described this random population [129, 119, 79,
102]. d) Double negative cells are illustrated in this figure. Again the x-axis shows the control and
starvation group. While the control group shows a mean value of 30259,2 cells/ml blood, the starvation
group's  mean is  again  lower,  counting 3474,1  cells/ml  blood.  However,  these  differences  are not
significant for p is 0,0955 (student t-test).
5.2 Function of leptin and its receptor
Leptin is a peptide hormone produced and secreted mainly by white adipocytes but
also by many other tissues such as hypothalamus, striped muscle, pituitary gland,
ovary,  placenta  and  also  in  lymphoid  organs  [139].  Leptin  unfolds  its  effects  by
binding  to  the  leptin  receptor  (LepR),  which  activate  several  signaling  cascades
already presented in the introduction. In this part we want to elucidate the type of the
receptor present on FRCs and the impact that binding of leptin receptor to its ligand
has.
5.2.1 Evidence of leptin receptor on FRCs
As mentioned earlier, we could prove that LepR is present on stromal cells of the
lymph node. Figure 23 shows the presence of  LepR on FRCs. The approach was
similar to that of the establishment of the staining scheme (5.1.1), with the exception
that a LepR-antibody and a FITC-related anti-goat-antibody, which binds to the LepR-
antibody  was  added  to  the  staining  mix.  We  can  see  a  shift  of  the  population
compared to the isotype control in the histogram, indicating that the whole population
is positive for  LepR. As this was a qualitative research in the early stages of this
work, this gating is not comparable to other examinations performed.
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Figure 23: Evidence of leptin receptor on FRCs: a)-f) are steps similar to figure 7. Subfigure g)
shows the staining for LepR in the FRC compartment of stromal cells, LepR has been stained with a
FITC-related  anti-goat-antibody,  which  binds  to  the  leptin  receptor  antibody.  Subfigure  h)  is  the
corresponding isotype control, goat IgG was used as isotype, it was labelled with FITC-related anti-
goat-antibody. When consulting i), a exemplary, yet representative histogram, it becomes obvious that
all of the FRCs have to bear LepR as the whole population shifts.
5.2.2 Determination of cell culture
In order to determine which type of leptin receptor is present on fibroblastic reticular
cells, we decided to use cultured cells, as it would enhance the protein output in
comparison to freshly isolated FRCs from mouse lymph node. To see which cell type
had  the  highest  level  of  leptin  receptor  on  their  surface,  we  performed a  FACS
analysis staining the leptin receptor (see figure 24). As we can see in this figure, the
CRL population has with 84,4% of all living single cells the highest number of cells
bearing the receptor. FRC-TN and FRC-T have been cultured in RPMI + 10%FBS +
1%P/S  +  1/1000  beta-Mercaptoethanol  +  HEPES  (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid), while CRLs hae been cultured in RPMI + 10%FBS +
1%P/S. These findings helped us to decide for the CRL population to extract protein
from. In this experiment, we used flow cytometry to evaluate the expression level of
LepR, flow cytometry however is not an adequate technique to investigate on protein
expression levels, a quantitative ELISA would be appropriate.
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Figure 24: Presence of leptin receptor on different cells: Figure 24 shows the presence of leptin
receptor on various spleen FRC derived cell lines, namely FRC 2, FRC-T and FRC-TN as well as a
bone marrow FRC derived cell  line (CRL). Also the gating for this investigation by the example of
CRLs is shown. Subfigure a) shows a debris exclusion according to the exemplary gating (figure 7a)).
b) Shows the doublets exclusion according to the exemplary gating (figure 7b)). c) Shows the dead
cell  exclusion  via  DAPI  similar  to  figure  7c).  d)  shows the  CRLs  with  an  FITC-related  anti-goat-
antibody, which binds to the LepR-antibody. The FITC channel is plotted on the y-axis whereas the
forward scatter is plotted on the x-axis. The leptin receptor positive gate contains 84,8% of the living
cells. e) Displays the gating of the isotype control (FITC channel plotted on the y-axis, forward scatter
plotted on the x-axis), 10% of the living cells are in the leptin receptor positive gate. The histogram in f)
shows a shift of the whole population when the isotype and the full  staining are compared (y-axis
normalized to mode, x-axis FITC channel). g) Shows the signal for leptin receptor on FRC-TN with
75,2% in the leptin receptor positive gate. j) Represents the FRC-TN isotype control with 9,52% of all
living cells in the leptin receptor positive gate. h) 57,7% of the living cells are in the leptin receptor
positive gate when looking at FRC-T. i) Also the FRC-2 is checked upon in this subfigure. With 40,8%
of all living cells being in the leptin receptor positive gate it is the population with the lowest leptin
receptor amount. Subfigure k) shows FRC-T and FRC-TN compared to the FRC-TN isotype control in
an histogram (y-axis normalized to mode, x-axis FITC channel). l) shows FRC-2 compared to FRC-TN
isotype control in an histogram (y-axis normalized to mode, x-axis FITC channel). In subfigure g)-j)
FITC channel is plotted on the y-axis and forward scatter plotted on the x-axis.
5.2.3 Receptor type
As mentioned earlier on, the leptin receptor comes in several isoforms, short ones
without an intracellular domain and a long one, which has an intracellular domain. In
our study we ruled out which receptor types are present on fibroblastic reticular cells.
In order to do so we performed a Western Blot with cell extract of protein which has
been extracted from those cultured cells. The Western Blots, both the control and the
actual experiment are shown in figure 25. Figure 25a) shows the blot with the leptin
receptor  and  figure  25b)  the  control,  which  is  gamma-tubulin.  We had  a  protein
solution of 1,202 mg protein/ml solution in total and used 754nl of this solution in
order to work with 1µg of protein. The left pocket is filled with pre stained dual color
marker  by  Bio-Rad  (Bio-Rad  Laboratories  Inc.,  Hercules,  USA),  whereas  the
following pockets  are filled,  from left  to  right,  with  5µg,  10µg,  20µg and 30µg of
protein. As mentioned earlier, there are several short and a long isoform of the leptin
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receptor, the size of the long isoform amounts 132,494 kDa (human) and 130,789
kDa (mouse)  and the  short  forms measure  around  100 kDa [208,  209].  For  the
control  we  used gamma-tubulin,  an  ubiquitous  protein  participating  in  microtubuli
motility, which molecular weight is around 48kDa. In figure 25b) we can clearly see
two bands, which lie around the 48kDa mark in all  pockets (5µg, 10µg, 20µg and
30µg), hereby proving that the protein isolation and the blotting of the membrane has
been successfully performed, making the experimental staining valid.  Surprisingly,
figure 25a) shows two bands in the pockets filled with 20µg and 30µg of protein, lying
approximately on the 130kDa and 100kDa mark [208, 209], which suggests not just
the presence of both, the long and the short, or rather several short isoforms of the
receptor and the long receptor, but gives also a hint on the amount of receptor in the
cell:  As in  the control  staining all  pockets showed a signal,  it  is  evident  that  the
concentration of leptin receptor is lower than that of gamma-tubulin.
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Figure 25: Determination of the leptin receptor type: This figure decrypts the type of leptin receptor
found on a CRL cell  line,  it  shows a Western Blot  membrane with a staining for the extracellular
domain of the leptin receptor and γ-tubulin as a control. The molecule weights are shown on the left
while the x-axis shows the amount of protein used in the pocket, being from left to right marker, 5µg,
10µg, 20µg and 30µg. The marker, pre stained dual color marker Bio-Rad, is filled into the left pocket
and marks the bands for a molecular weight of, from upper to lower, 260kDa, 140kDa, 100kDa, 70kDa,
50kDa and 40kDa. In a) where the leptin receptor is stained, one clearly sees bands at approximately
130kDa and again at approximately 100kDa in the 20µg and 30µg pocket, representing the long and
the short isoform of the receptor. b) Represents the gamma-tubulin control with bands in all pockets
(5µg, 10µg, 20µg and 30µg) between 50kDa and 40kDa.
5.2.4 Impact of leptin receptor-binding
Leptin, as stated in the introduction, is not just a regulator of the feeling of satiety, but
also involved in homeostasis of the immune system, a reasonable suspicion is raised
that during starvation and regression, this hormone would have a crucial effect on the
structure of the lymph node. Especially as fibroblastic reticular cells interact with the
immune system and express LepRb. As leptin is excreted upon feeding and being
absent upon famine, we postulated that a resubstitution of leptin during the starvation
phase  would  have  a  supporting  effect  on  survival  of  FRCs.  To  perform  this
experimental setting, the animals which suffered starvation received daily after the
beginning of the starvation phase an intraperitoneal injection of 1µg leptin/g mouse
(20µg in 80µl PBS prediluted), as in the preceding experimental settings, they have
been killed 48h after the begin of the starvation phase, also a group of mice which
suffered starvation, yet didn't receive any leptin injections, served as negative control
group and a group of mice on regular diet served as a control group. A regression
group  couldn't  be  checked  but  would  surely  have  been  desirable.  Only  female
C57Bl/6 mice aged 7 to 8 weeks have been used. The following part  shows the
results  determined  by  this  experiments.  However,  this  experimental  setting  only
includes the control group and the starvation group. Furthermore, n has been very
small, so no valid statistical analysis is possible with this data
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5.2.4.1 Impact on fibroblastic reticular cells
Earlier,  we  described  the  effects  of  starvation  and  regression  on  the  fibroblastic
reticular  cells.  This  part  sheds  light  on  the  effect  of  additional  leptin  during  the
starvation phase. Figure 26 leads us through the results. While figure 26a) and b)
give an overview about how the effects of leptin during starvation look like in the
different cell types and mouse models by juxtaposing them, c)-f) go more into detail,
on their y-axis they show the number of cells per lymph node and on their x-axis the
mouse model, the medium bar represents the mean while the upper and lower bar
include the 95% confidence interval. c) Broaches the issue of fibroblastic reticular
cells. In the control group, which has received a regular diet, the mean of cells per
lymph  node  counts  365  cells  per  lymph  node.  The  negative  control  group,
comparable  to  the  starvation group in  the regular  experiments  mentioned above,
shows a similar result  with a slightly higher mean, namely 401,5 cells per lymph
node. As it was the case in the control group, also in this group n counted 2 and is
therefore not consultable for valid statistical analysis. The last model is the starvation
group injected with leptin during starvation. During leptin input, the number of FRCs
more than doubles (mean(starvation+leptin)=886,5 cells/ lymph node). Again in the
last  group,  n  was 2,  therefore  forbidding  a valid  statistical  analysis.  Yet,  if  these
experiments can be confirmed, this would show that the maintenance of a high leptin
level during starvation could prevent FRCs from cell death in the regression phase,
as the number of FRC rises during leptin treatment.
5.2.4.2 Impact on lymphatic endothelial cells
Similar to the previous point, this section covers the effects of leptin treatment on
lymphatic  endothelial  cells,  again  figure  26  will  accompany  us  to  depict  the
happenings during leptin treatment under starvation. Figure 26 covers absolute cell
numbers (being written on the y-axis, while the x-axis is showing the mouse model).
The medium bar again shows the mean while the upper and the lower bar include the
95% confidence interval. Subfigure 26d) illustrates the happenings in the lymphatic
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endothelial cells' fraction. As in the preceding figures, the control group, shown in the
first column, has the smallest range of the three groups, enclosing a mean of 232
cells/ lymph node. In the starvation group which didn't receive a leptin injection,the
mean undermatches that of the control group (mean(starvation without leptin)=204
cells/ lymph node). The last group is that of the starvation group that was treated with
leptin injections during their starvation phase. The mean exceeds the means of the
other groups being 455 cells/ lymph node. The number of test subjects used in every
group was 2, so statistical analyses are not valid. But again, if these data confirms, a
protective effect of leptin on LEC survival can be stated.
5.2.4.3 Impact on blood endothelial cells
Figure 26e) illustrates the impact of leptin treatment during starvation (third column)
and also depict a control group (first column) and a negative control group (second
column). In the control group, a mean of 240,5 cells/ lymph node is the highest value
of the three groups. The control group is followed by the starvation group without
leptin injections, the marking points of its range is obviously lower than that of the
control group. The mean of this group is the lowest of all three groups with 155 cells/
lymph node. The mean of the starvation group which received leptin treatment lies
between  the  two  other  groups,  being  205,5  cells/  lymph node.  In  all  groups the
number of test subjects has been 2. As only two test subjects participated in this
experimental  setting,  a  valid  statistical  statement  cannot  be  given.  But  again,  it
seems  like  leptin  treatment  stabilizes  cell  populations  during  starvation,  as  cell




Figure 26: Effect of leptin on stromal cells: This figure illustrates the effect on leptin on the state of
starvation with absolute numbers denoted as cells per lymph node on the ordinate. The abscissa in a)
shows the cell type while in all other subfigures it shows the mouse model. Subfigure a) and b) give an
overview about the distribution of the cell types within the mouse model. The mean value is given by
the medium bar, and the 95% confidence interval is given by the upper and lower bar. Looking at
absolute numbers, no significant change in leptin injected animals to starving animals without injection
or healthy controls could be verified. N is 2 for all models. c)(p=0,4447; student t-test) d)(p=0,5781;
student t-test) e)(p=0,51; student t-test) f)(p=0,4669; student t-test).
5.2.4.4 qPCR
To further understand the FRCs' physiology under the influence of leptin, we tried to
analyze the FRCs' expression pattern during different situations. As we know that
these cells express LepR, we examined how the addition of leptin would interfere.
For this experiment we used a MACSed primary culture of murine lymph node FRCs.
We had different experimental setups: 
24h incubation with 50ng leptin/ml
24h incubation with 250ng leptin/ml
24h incubation with 1000ng leptin/ml
24h incubation with 50ng leptin/ml + 50ng IFNγ/ml + 50ng TNFα/ml
24h incubation with 250ng leptin/ml + 50ng IFNγ/ml + 50ng TNFα/ml 
24h incubation with 1000ng leptin/ml + 50ng IFNγ/ml + 50ng TNFα/ml 
24h incubation with 50ng IFNγ/ml + 50ng TNFα/ml as positive control
untreated samples as negative control
After the incubation, mRNA has been isolated and cDNA has been generated. Then a
qPCR has been performed to check on different expression patterns. The expression
of GAPDH served as control. We hypothesized that leptin itself would change the
cellular  expression  pattern  and  the  addition  of  leptin  to  IFNγ  and  TNFα  would












However the melting curves of the designed primers were not appropriate and the
multiplications were most likely primer dimers, therefore, results of the PCR analysis
are  not  utilizable.  Nevertheless  a  genetic  analysis  is  promising,  especially  the
expression of LepR under different conditions. qPCR could be used to clarify the
question in how far the composition of the different LepR isoforms on the FRCs'
surface changes under different conditions. Also the effect of gp38 in the regression
phase could be investigated by checking again on SMA in the control group and the
regression group. An increase in SMA expression would back up the hypothesis that
a blockade of podoplanin signaling stimulates the expression of SMA [1, 11, 26] and




6.1 Lymph node structure
Healthy control mice consisted of female C57BL/6J aged to approximately 9 up to 11
weeks. The mice were provided dry food and water ad libitum. Figure 15 gives an
overview about the distribution of stromal cells as well as leukocytes. As one can
see,  the  biggest  population in  healthy mice's  stromal  cell  compartment  is  that  of
FRCs, secondly come the LECs, followed by BECs. The biggest amount of cells is as
mentioned earlier build up by leukocytes. The direct comparison between healthy and
starving mice on cellular base regarding lymph node structure does not show striking
differences between the two models. Surprisingly, during recovery, a massive drop in
numbers in all resident lymph node cells occurs, next to the stromal compartment.
Also  leukocytes  and  dendritic  cells  are  heavily  affected  (see  figure  15  and  17).
Looking at FRCs (see figure 9 and figure 10), there is neither a significant difference
nor  a  tendency  towards  any  direction  visible  when  comparing  normal  nutritional
status with famine. Also the means of both models do not scatter apart and stay
closely together. The highest values in cell count though belong to the control group,
maybe the phase of starvation is not long enough for any effect to become manifest.
After 48h of recovery however, we see a heavy and significant drop in resident FRCs,
their number more than halves compared to the control and starvation group. Analog,
in  the  LEC fraction,  there  are  no  differences  in  the  arrangement  of  LECs when
looking at  the control  and starvation model  (see figure 11 and figure 12).  Also a
tendency does not strike the eye as the mean values of both models stay closely
together. The previously described cell death during recovery also has its equivalent
in this stromal faction, the LECs' population also more than halves during regression
compared to the control and starvation group. A similar picture is presented by the
BEC partition (see figure 13 and 14) where no evidence of a direct effect of starvation
on the absolute cell number compared to the control group is given, the difference
between both models is not significant. Alike FRCs and LECs, also here the means
do not disperse much when comparing the control group with the starvation group.
But even in this small group of stromal cells we can see a significant effect during
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reuptake of nutrition, the numbers of BECs fall in lymph nodes. When taking a closer
look at figure 15f), we can clearly see that also leukocytes seem to stay unaffected by
a phase of reduced food uptake short-term. Again, this status cannot be maintained
during nutritional recovery, as the absolute number of leukocytes within the lymph
node drops dramatically. Whether leukocytes become the victim of cellular death or
just migrate out of the lymph node remains unclear, as we only focused on circulating
lymphocytes during starvation, no significant differences between the control group
and the starvation group were detectable in this experimental setting. While CD11c
high+ DCs stay untouched by famine, CD11c low+ DCs seem to drop in numbers, at
least in lymph nodes. To investigate the possible share of FRC and LEC loss caused
by dendritic cell death, mean and median APC fluorescence of FRCs and LECs has
been  looked upon,  as  gp38  is  labeled with  a  staining  that  appears  in  the  APC-
channel. Acton et al. as well as Astarita et al. state in their paper that DCs are able to
support FRC survival by binding the FRCs' podoplanin with their CLEC-2, next to
increased FRC survival, the blocking of podoplanin causes the reticular fibre network
to become more elastic [1, 11]. As we see in figure 20, the median APC fluorescence
of FRCs drops in the regression phase, this could be an adaptation to the cell death
of FRCs. As there are less FRCs present in the lymph node, the remaining FRCs are
challenged with the maintenance of the reticular fibre network by downregulation of
podoplanin. To further develop the idea of Acton et al. and Astarita et al., FRCs are
probably able to compensate the lower cell count by stretching their reticular fibre
network.  In  order  to  confirm  this  hypothesis,  a  histological  examination  with  an
antibody staining for podoplanin would be necessary. This data contradicts the idea
that a decrease in FRC or LEC numbers is owed to DC death or DC emigration,
rather would one expect an elevated level of gp38 expression. The contrary is the
case, a low g38 signal connected with a low DC count gives a hint on DC emigration
due to  the  downregulation  of  podoplanin,  as  the migration  of  DCs alongside the
reticular fibre network is dependent on CLEC-2/gp38 binding [26]. All these findings
indicate a severe structural alteration within lymph nodes, at least after the phase of
famine. In what exact phase the change happens remains unclear, as well as the
time point when the lymph node's structure fully recovers. In order to shed light on
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this  question,  an  examination  via  flow  cytometry  could  be  performed  72h  after
resubstitution of food. 
6.2 T-cells and B-cells in blood
As T-cells, B-cells and DCs travel along the reticular fibre network, we hypothesize
that this structural change also has a high impact on the homeostasis of cells of the
acquired immune system. A flow cytometry analysis has been made to examine the
status of B- and T-cells circulating in the mice's blood during steady state and famine.
The outcome of this investigation does not show a striking outcome, as both groups
show  similar  results.  In  the  results  we  can  see  a  special  population  of  cells,
CD19/CD3e double positive cells (see figure 21 and figure 22), as mentioned in the
legend of figure 22,  they are most  likely artifacts  caused by the storing process,
several  publications  name different  reasons  for  CD19/CD3e double  positive  cells
[129, 119, 79, 102]. However with much higher experimental repetitions and also the
inclusion  of  the  regression  phase  into  this  research,  a  significant  difference  is
imaginable.
6.3 Cell culture
Originally, the main task of this research was to study the physiology of the leptin
receptor expressed by FRCs (see 5.2.1), this proofed to be harder than expected.
First we wanted to set up a FRC primary culture, the material of the digested mouse
lymph nodes would be taken into culture. The stromal cells will need 24h to adhere to
the bottom of the culture plate, nonadherent cells will be floating in the medium and
can  be  washed  out,  regular  change  of  medium will  eradicate  BECs and  double
negative cells. Next to FRCs, macrophages, dendritic cells and LECs will survive in
this culture. Once the culture is fully grown, it can be expanded. When enough cells
have been generated, FRCs can be isolated by MACS. After we established several
primary  cultures,  we  tried  to  isolate  LepR  positive  FRCs  via  cell  sorting.  This
technique proofed to be very error-prone: There are many steps which are sensible
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to  contamination,  as  cells  are  often  resuspended  and  are  in  contact  with  many
different  materials,  this  also  leads  to  an  enormous  cellular  stress.  Regularly,  the
survival of FRCs due to these conditions was too low to generate a population which
is big enough for analysis. As the whole procedure is time consuming and next to it,
the output of  FRCs is not very high, we distanced from primary cultures. A more
reliable and fail-safe source of LepR positive FRCs was the establishment of a cell
line.  To  do  so,  we  first  needed  to  identify  the  cell  line  which  has  the  highest
expression level of LepR. We used flow cytometry to check on expression levels of
LepR, this allowed us to find a suitable population. Figure 24 explains the approach
of this procedure. There were four possible FRC-populations: FRC-T, FRC-TN, FRC-
2 and CRL. The dot-plots and histograms confirm that the cell line with the highest
LepR expression are the CRL cells. However, flow cytometry usually isn't convenient
for  the  detection  of  expression  levels,  a  better  solution  would  have  been  a
quantitative  ELISA.  The  CRL cells  were  taken  into  culture.  After  expanding  and
harvesting the cells, they have been used for further experiments. Next to FRCs and
CRL cells, many other stromal subsets express LepR, such as thymic stromal cells
[136, 73], as well as bone marrow stromal cells [204, 161, 157, 54, 207]. One could
say that the expression of LepR is common among stromal cells.
6.4 Leptin receptor
One of the most promising result of our research was the identification of the leptin
receptor  in  FRCs.  For  there  are  several  isoforms,  many short  isoforms and one
functional  long isoform. Most authors share the idea stated by Bjørbaek et  al.  in
1997, that only the long isoform is functional in vivo [23, 116, 69]. Thus it is of interest
to detect which one is present on the FRCs' surface. Normal flow cytometry analysis
is not capable to differentiate the isoforms as the leptin receptor antibody binds to the
extracellular domain of the receptor which is identical in all isoforms. The difference
lays in the intracellular domain. The Western blot technique allowed us to check on
the protein's length and, indeed, we discovered two bands when staining for LepR.
That means that next to the short isoform, also the long and functional isoform of
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LepR is present on FRCs. The short isoform has not been classified in this work. It is
however likely that the receptor present on these cells is Ob-Ra, which is widely
expressed [60]. The presence of both isoforms, especially the presence of the knock-
out receptor raises questions. A hypothetical but possible answer is that the potential
of expressing both isoforms enables the cell to autoregulate the effects of leptin: An
upregulation of the expression of knock-out LepR and a steady expression, or even
downregulation of the expression of functional LepR could impair the effect of leptin
on the target cell by raising the probability of leptin/LepR-binding to the knock-out
receptor. Similar to that idea, Cao et al. underline the statement of Ahima et al. and
Myers et al. based on the findings of Clément et al. as well as Ge et al., that the
soluble form of LepR may regulate the concentration of circulating leptin by binding it
[30, 4, 127, 42, 68]. Friedman et al. hypothesized 20 years ago, that the short isoform
Ob-Ra could be responsible for the transport of leptin beyond the blood-brain barrier
and the clearance of leptin, which supports my hypothesis [64, 17, 180]. Yet another
possibility  is  that  the  short  isoforms indeed inhere  a  signal  transducing function:
OBRs (this is how Bjørbaek et al.  designated the short isoform described in their
work) is supposed to be capable of activating signal transduction via JAK2, as well as
IRS-1 tyrosine phosphorylation [23, 116]. Bacart et al. attribute a physiological role to
Ob-Ra  as  they  showed  that  in  presence  of  leptin,  several  LepR  isoforms  on
HEK293T cells form heteromers, in this special case they detected Ob-Ra/b and Ob-
Rb/c  heteromers.  The  work  group  around  Bacart  et  al.  suspect  that  the
heteromerization could have an effect on the half-life of Ob-Rb [12]. In order to shed
light on that question, a quantitative Western blot  or qPCR examination could be
performed on leptin-incubated FRCs. A change in the expression pattern of the short
isoform LepR would proof this hypothesis.
6.5 Influence of leptin
As we have proven that famine and a follow-up recreation phase heavily changes the
murine lymph node's structure, we wanted to investigate whether leptin treatment
could slow down, or  even prevent  these happenings.  Leptin  is  a  hormone which
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mediates the feeling of saturation, but next to that, it has various influences on the
immune  system.  After  famine,  the  lymph  node's  cellular  structure  changes
dramatically. As FRCs bear the receptor for leptin on their surface and are closely
linked to T-cell maintenance and survival, the supplement of leptin during starvation
may  reduce  cell  death  or  maybe  even  prevent  it.  The  addition  of  leptin  during
starvation  seems to  have  a  supportive  effect  on  FRC survival,  maybe  even  the
proliferation of these cells is supported by additional leptin: The average count of
FRCs  per  lymph  node  rises  under  experimental  conditions  compared  to  the
starvation only group. A similar effect can be observed when looking at LECs. Their
population seems to  stay unaffected during famine.  Under  the influence of  leptin
though, the number of LECs seems to rise. As already stated above, FRCs support
T-cell survival and maintenance. I hypothesize that a drop down in numbers of FRCs
during regression or  late  starvation phase will  have a serious influence on T-cell
function and therefore cause a heavy impact on an adequate immune response. A
stable FRC population during the regression phase or late starvation phase could
prevent a negative effect on the immune response. This goal could be reached by the
supplementation of leptin during famine. Starvation in general severely affects the
immune  system  by  immunosuppressive  effects  [6].  For  instance,  Cason  et  al.
described a reduced delayed hypersensitivity reaction as well as a light leucopenia
with a reduced T3+ and T4+ count in anorexia nervosa patients [31]. Furthermore,
the  production  of  interferon-γ  (IFN-γ)  by  peripheral  lymphocytes  seems  to  be
impaired in these patients [143]. Lord et al. proved that leptin stimulates proliferation
in peripheral blood lymphocytes, their data showed that mainly CD4+ T-cells were
affected by the proliferative properties of leptin/LepR signaling. However the effects
of leptin on T-cells are ambivalent, as cytokine production of Th1 cytokines, like IL-2
and IFN-γ is enhanced in the presence of leptin, while production of Th2 cytokines
such as IL-4 is hampered. Additionally,  the impaired delayed type hypersensitivity
reaction during starvation could be restored by the supplementation of leptin during
the hunger phase [104]. It remains to be investigated whether leptin influences also
stromal cell function within SLOs.
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6.6 Outlook: Possible clinical connection of stromal leptinR expression in 
patients
The  scenario  of  the  above  mentioned  settings  is  not  devious:  Next  to  anorexia
nervosa patients, a lot of cancer patients suffer from undernutrition caused by their
wearing disease. This is a problematic issue during cancer treatment, as this leads to
physical  katamorphism  and  increased  vulnerability  towards  infectious  diseases.
Cancer cachexia is associated with a bad prognosis and higher mortality [55, 197,
181, 158]. Cancer cachexia itself seems not to be mediated by leptin, but somehow
by  the  tumor,  the  pathogenesis  behind  this  serious  complication  is  not  fully
understood [55]. Leptin treatment could, next to replenishment of nutrients, be a key
player  in  supportive  cancer  treatment  as  it  could  be  protective  at  least  towards
infectious diseases such as nosocomial pneumonia. A drawback of additional leptin
during cancer treatment could be the inhibition of hungry feeling, as one of the first
known  effects  of  leptin  is  the  mediation  of  the  feeling  of  satiety.  This  would  be
counterproductive  and  even  harmful  to  the  patient,  as  food  uptake  must  be
maintained under all circumstances. In a study performed by Demiray et al., leptin
levels reciprocally correlate with the overall  survival of patients with non-small-cell
lung carcinoma (NSCLC) [55]. Serum leptin levels are in general lower in patients
with cancer cachexia, this could be linked to a reduced amount of body fat [55, 155],
however,  Demiray  et  al.  state  that  overall  survival  is  higher  when  low  levels  of
circulating leptin are detected [55], which seemingly contradicts the statement that
cancer cachexia is one of  the main reasons for death during malign disease, as
cachexia is supposed to correlate with low levels of leptin. A separation between non-
cachexia and cachexia patients did not happen in this study when calculating the
overall survival linked to leptin levels. This would have been of interest, as this could
show how many of the deceased patients with cachexia had low levels of leptin and
how many of these patients had high levels of circulating leptin. As this study only
examined a low number of  patients,  it  is  possibly not representative.  In  contrast,
Karapanagiotou cannot provide evidence for a drop in leptin levels during weight loss
in patients with NSCLC, furthermore they state that overall survival does not correlate
with serum leptin level [86]. Studies focussing gastrointestinal malignoma established
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a claim that leptin levels drop in patients with gastric and colorectal cancer [24, 57].
Yet  another  study,  performed by Brown et  al.  on patients  with  pancreatic  cancer
showed no significant correlation between cachexia and leptin level or appetite loss
and leptin level [25]. Furthermore, Simons et al. underline, that especially high leptin
levels  are  not  responsible  for  cancer  cachexia  [170].  To  further  understand  the
causality and correlation between tumor cachexia and leptin, further studies with a
high number of patients have to be performed as literature shows diverging results.
This  problem  probably  does  not  come  to  full  play  during  intravenous  nutrition.
However, intravenous nutrition is not an alternative to oral nutrition when the patient
does not lack the ability to oral food uptake. Nevertheless, therapeutic addition of
leptin  is  not  a  novum,  it  is  already state  of  the  art  in  patients  who  suffer  from
congenital  leptin  deficiency,  lipodystrophy  and  hypothalamic  amenorrhea.  These
diseases are based on a mutated leptin gene [141]. Leptin treatment started in 1997,
when congential leptin deficiency was first discovered in humans. The phenotype of
these  patients  resembles  is  comparable  to  the  phenotype  of  ob/ob-mice:  early
obesity, probably caused by the down regulation of the feeling of satiety and resulting
hyperphagia due to the low levels of leptin. Also hyperinsulinemia is described in
these patients. Treatment of these patients with r-metHuLeptin resulted in the raise of
CD4+ naive T-cell  numbers.  Additionally the treatment also resulted in significant
weight loss [140], which is advantageous for the patients described by Paz-Filho et
al., however this is not the case in cancer patients, were weight loss would have a
dramatic  impact.  Contrariwise the treatment  of  common obesity seems not  to  be
possible  due  to  leptin-resistance  [141,  175].  Other  described  side  effects  of
metreleptin (the currently used drug for treatment) include abdominal pain, headache
and  hypoglycemia  [141],  whether  r-metHuLeptin  has  these  side  effects  is  not
mentioned, yet seems likely.  Another interesting finding is that in one patient with
diabetes mellitus type 2, higher doses of leptin were necessary to achieve positive
effects. The explanation could be the leptin resistance caused by diabetes induced
obesity  [140].  A  draw-back  of  the  study  of  Paz-Filho  et  al.  mentioned  in  the
publication from 2011/2010, is owed to the rareness of this disease, namely the low
number  of  examined  cases.  Not  just  the  treatment  of  tumor  cachexia  is  an
imaginable scenario, in rodents, leptin deficiency also causes a diabetes type II like
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phenotype with insulin resistance and hyperglycemia, treatment with leptin reversed
these effects by the reduction of serum glucose and insulin,  proving a stabilizing
function of leptin in this common metabolic disease [142].
Taken  together,  it  is  possible  that  leptin  related  changes  regarding  stromal  cell
function  could  add  and  influence  cancer-related  cachexia  and  other  nutritional
disorders. 
Future experiments and clinical studies are necessary to clarify these questions.
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